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Abstract
Mood and anxiety disorders are common during pregnancy and the postpartum period. The goal of this
dissertation was to investigate factors specific to the perinatal period related to the development, treatment,
and prevention of depression and anxiety. In Chapter 1, we investigated the role of a risk factor specific to the
perinatal period: maternal attitudes. We developed a measure of this construct and used this measure to assess
the relationship between these attitudes and symptoms of depression and anxiety among first-time pregnant
and postpartum mothers. Dysfunctional maternal attitudes predicted symptoms of depression and anxiety,
and these attitudes had incremental predictive validity over general cognitive biases and interpersonal risk
factors. In Chapters 2 and 3, we conducted meta-analyses assessing the efficacy of interventions for depression
among perinatal populations and investigated whether characteristics of study design and interventions were
associated with systematic differences in effect sizes. In Chapter 2, we included 27 studies assessing the
efficacy of treatments for depression during pregnancy and the first year postpartum. We found that
interventions resulted in significant reductions in depressive symptoms from pre-treatment to post-treatment,
and symptom levels at post-treatment were below cutoff levels indicative of clinically significant symptoms. At
post-treatment, intervention groups demonstrated significantly greater reductions in depressive symptoms
compared to control groups. In Chapter 3, we included 37 studies assessing the efficacy of preventive
interventions for postpartum depression. We found that depressive symptoms at six months postpartum were
significantly lower in intervention conditions as compared to control conditions, and there was a significant
reduction in the prevalence of depressive episodes in treatment conditions compared to control conditions.
These studies further our understanding of the processes that place women at risk for emotional distress in the
context of pregnancy and the postpartum period and suggest that a wide range of interventions are effective
for treating and preventing depression in this population.
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ABSTRACT 
THE DEVELOPMENT, TREATMENT, AND PREVENTION OF PERINATAL MOOD 
AND ANXIETY DISORDERS 
Laura E. Sockol 
Jacques P. Barber  
Mood and anxiety disorders are common during pregnancy and the postpartum period. 
The goal of this dissertation was to investigate factors specific to the perinatal period 
related to the development, treatment, and prevention of depression and anxiety. In 
Chapter 1, we investigated the role of a risk factor specific to the perinatal period: 
maternal attitudes. We developed a measure of this construct and used this measure to 
assess the relationship between these attitudes and symptoms of depression and anxiety 
among first-time pregnant and postpartum mothers. Dysfunctional maternal attitudes 
predicted symptoms of depression and anxiety, and these attitudes had incremental 
predictive validity over general cognitive biases and interpersonal risk factors. In 
Chapters 2 and 3, we conducted meta-analyses assessing the efficacy of interventions for 
depression among perinatal populations and investigated whether characteristics of study 
design and interventions were associated with systematic differences in effect sizes. In 
Chapter 2, we included 27 studies assessing the efficacy of treatments for depression 
during pregnancy and the first year postpartum. We found that interventions resulted in 
significant reductions in depressive symptoms from pre-treatment to post-treatment, and 
symptom levels at post-treatment were below cutoff levels indicative of clinically 
significant symptoms. At post-treatment, intervention groups demonstrated significantly 
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greater reductions in depressive symptoms compared to control groups. In Chapter 3, we 
included 37 studies assessing the efficacy of preventive interventions for postpartum 
depression. We found that depressive symptoms at six months postpartum were 
significantly lower in intervention conditions as compared to control conditions, and 
there was a significant reduction in the prevalence of depressive episodes in treatment 
conditions compared to control conditions. These studies further our understanding of the 
processes that place women at risk for emotional distress in the context of pregnancy and 
the postpartum period and suggest that a wide range of interventions are effective for 
treating and preventing depression in this population.   
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General Introduction 
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 Perinatal depression and anxiety are common psychological disorders with 
important public health implications. Approximately 10-15% of women experience a 
depressive episode during pregnancy or the first year postpartum (Bennett, Einarson, 
Taddio, Koren & Einarson, 2004; Joseffson, Berg, Nordin & Sydsjo, 2001). Anxiety 
disorders are also common during pregnancy (Lee, Lam, Lau, Cong, Chui, & Fong, 
2007) and the first year postpartum (Stuart, Couser, Schilder, O’Hara, & Gorman, 1998; 
Wenzel, Haugen, Jackson, & Brendle, 2005). While clinicians previously believed that 
pregnancy was protective against mental illness, we now know that the risk of mental 
illness is at least comparable between childbearing and non-childbearing women 
(O’Hara, Zekoski, Philipps, & Wright, 1990), and there is some evidence that women are 
at increased risk for psychopathology during the perinatal period (Eberhard-Gran, Eskild, 
Tambs, Samuelsen, & Opjordsmoen, 2002; Eberhard-Gran, Tambs, Opjordsmoen, 
Skrondal, & Eskild, 2003).  
 The context in which women with perinatal depression and anxiety experience 
their symptoms is important to consider in order to fully understand these disorders. The 
distress experienced by women with these disorders is often exacerbated by feelings of 
guilt and isolation that accompany women’s perceptions that their experiences deviate 
from cultural norms and expectations (Mauthner, 1999). Clinicians may not identify 
women experiencing these disorders due to beliefs that pregnancy is protective against 
mental illness (Cohen et al., 2006). Difficulty distinguishing between normal responses to 
the stresses of pregnancy and parenting, the “baby blues,” and psychopathology can also 
result in a failure by women and their physicians to identify psychological disorders 
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during this time. Even when women at-risk for psychological difficulties are identified 
during pregnancy and the early postpartum period, the majority do not receive treatment 
for their symptoms (Horowitz & Cousins, 2006).  
 In addition to the distress experienced by women who experience perinatal 
depression and anxiety, these disorders confer additional risk on the developing fetus and 
child. Depression during pregnancy is associated with increased risk for preterm birth, 
low birth weight, intrauterine growth restriction, and preeclampsia (Grote, Bridge, Gavin, 
Melville, Iyengar, & Katon, 2010; Kim, Sockol, Sammel, Kelly, Moseley, & Epperson, 
2012). Prenatal anxiety is also associated with poor birth outcomes (Littleton, Breitkopf, 
& Berenson, 2007). Children of depressed and anxious mothers are at increased risk for a 
wide range of problems. Maternal depression during the first year postpartum is 
associated with long-term behavioral problems, emotional difficulties, and impaired 
cognitive development, particularly among boys and children of low socioeconomic 
status (Grace, Evindar, & Stewart, 2003). Maternal anxiety is also associated with 
increased risk for behavioral and emotional difficulties (O’Conner, Heron, Glover, & the 
ALSPAC Study Team, 2002).  
 Identification of risk factors for perinatal depression and anxiety can help guide 
researchers and clinicians in identifying women at-risk for these disorders and suggest 
potential targets for intervention and prevention. Epidemiological research has identified 
many risk factors for these disorders. A personal or familial history of depression or an 
anxiety disorder is among the strongest predictors that a woman will experience 
depression or anxiety during pregnancy or the first year postpartum (C. Beck, 2001; 
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O’Hara & Swain, 1996; Robertson, Grace, Wallington, & Stewart, 2004). Women who 
are members of racial/ethnic minorities, single women, and women of low 
socioeconomic status are at increased risk for depression and anxiety (C. Beck, 2001; 
Littleton, Breitkopf, & Berenson, 2007; O’Hara & Swain, 1996; Robertson, Grace, 
Wallington, & Stewart, 2004). Interpersonal stressors, including a lack of social support 
and low marital satisfaction, are also associated with increased risk (C. Beck, 2001; 
O’Hara & Swain, 1996; Robertson, Grace, Wallington, & Stewart, 2004). Psychological 
characteristics associated with increased risk for these disorders include perfectionism 
and a negative attributional style (C. Beck, 2001; O’Hara & Swain, 1996; Robertson, 
Grace, Wallington, & Stewart, 2004).  
While these risk factors can help clinicians and researchers identify women at-risk 
for distress during the transition to parenthood, it is important to note that many of these 
risk factors are challenging targets for intervention. An important goal for research in this 
area is the identification of risk factors that can serve as targets for prevention and 
intervention. Beck’s cognitive model provides an approach to conceptualizing these 
disorders that suggests risk factors that may be amenable to intervention. According to 
this model, the relationship between an individual’s experience and his emotional 
response is mediated by cognitive processes (A. Beck, 1967; 1976; 1985). Maladaptive 
emotional responses, such as depression and anxiety, result from systematic biases in 
cognition. Importantly, these biases can be targeted through psychological interventions, 
particularly cognitive-behavioral therapies (Appleby, Warner, Whitton, & Faragher, 
1997; Cooper, Murray, Wilson, & Romaniuk, 2003).  
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It is also important for research to identify risk factors that may be specific to 
perinatal psychopathology. There is evidence that a subset of women who are particularly 
vulnerable to depression and anxiety during the perinatal period are not otherwise at risk 
for these disorders (Bloch, Schmidt, Danaceau, Murphy, Nieman, & Rubinow, 2000; 
Cooper & Murray, 1995). Beliefs and attitudes related to motherhood may function as a 
specific cognitive vulnerability to depression and anxiety in the context of pregnancy and 
the transition to parenthood. There is evidence that maternal attitudes are associated with 
poor psychological adjustment for pregnant and postpartum women (Sockol, 2008; 
Warner, Appleby, Whitton, & Faragher, 1997). However, research in this area has been 
limited by conceptual and psychometric problems with measures commonly used to 
assess maternal attitudes (Sockol, 2008).  
Identification of women at risk for perinatal depression and anxiety may help 
clinicians and researchers identify women who would benefit from preventive 
interventions. Research has investigated the efficacy of a wide range of interventions to 
reduce the prevalence of psychopathology during the perinatal period. The perinatal 
period may be a particularly opportune time to initiate preventive interventions, as 
pregnancy and the early postpartum period are times of increased healthcare utilization 
and access.   
While research suggests that the prevalence of depression and anxiety can be 
reduced through preventive interventions, high-risk individuals who receive these 
interventions often develop psychological disorders (Cuijpers, van Straten, Andersson, & 
Van Oppen, 2008; Zalta, 2011). Given the prevalence and consequences of these 
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disorders, the identification of effective treatments has important public health 
implications. Concerns unique to the perinatal period may influence the efficacy of 
treatments for perinatal women (Kim, O’Reardon, & Epperson, 2010). Due to concerns 
about fetal exposure to antidepressants, concerns about breastfeeding, and the need for 
higher doses of medication during pregnancy, medications may be prescribed below 
therapeutic levels (Bennett, Einarson, Taddio, Koren, & Einarson, 2004; Dawes & 
Chowienczyk, 2001; Epperson, Anderson, & McDougle, 1997; Epperson, Jatlow, 
Czarkowski, & Anderson, 2003; Hostetter, Stowe, & Strader, 2000; Wisner, Perel, & 
Wheeler, 1993). Biological and psychosocial changes that occur in the context of 
pregnancy and parenting, including sleep deprivation, disruptions to the hormonal milieu, 
alterations to HPA axis functioning, and changes to interpersonal relationships, introduce 
challenges that may affect the efficacy of both pharmacological and psychotherapeutic 
interventions (Dennis & Ross, 2005; Kammerer, Taylor, & Glover, 2006). There are also 
concerns related to the acceptability of interventions for perinatal psychopathology: the 
majority of women indicate a preference for psychological interventions to medication 
during both pregnancy and the postpartum period, and the overall acceptability of 
pharmacotherapy among these groups is low (Chabrol, Teissedre, Armitage, Danel & 
Walburg, 2004; Kim et al., 2011). Thus the identification of efficacious interventions, 
particularly psychological interventions, for this population is an important and growing 
area of research.  
 The goals of the studies included in this dissertation are to further our 
understanding of the development, treatment, and prevention of mental illness during 
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pregnancy and the first year postpartum. In Chapter 1, we developed a measure for 
assessing maternal attitudes, a potential risk factor for perinatal depression and anxiety. 
We then used this measure to assess the predictive validity of maternal attitudes in 
relation to symptoms of depression and anxiety among first-time mothers, and to 
investigate the relationship between maternal attitudes and other known risk factors for 
these disorders. In Chapter 2, we conducted a quantitative review of the literature on the 
treatment of depression during pregnancy and the first year postpartum. We used meta-
analysis to assess the overall effectiveness of interventions for perinatal depression by 
assessing changes in depressive symptoms over time and the differences between 
treatment and control conditions in randomized and quasi-randomized trials of 
interventions for these disorders. We also assessed whether characteristics of studies and 
interventions were associated with systematic differences in effect sizes. Finally, in 
Chapter 3, we conducted a quantitative review of the literature on the prevention of 
postpartum depression. We used meta-analysis to assess whether preventive interventions 
are associated with decreased levels of depressive symptoms and reduced incidence of 
depressive episodes during the first six months postpartum. As in Chapter 2, we also 
assessed whether characteristics of studies and interventions were associated with 
systematic differences in effect sizes. Overall, these studies further our understanding of 
the mechanisms by which perinatal depression and anxiety disorders develop and the 
most effective ways to treat and prevent them.  
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Chapter 1: 
The Relationship Between Maternal Attitudes and Symptoms of Depression and Anxiety 
Among Pregnant and Postpartum First-Time Mothers 
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Abstract 
Two studies examined the role of attitudes toward motherhood in relation to symptoms of 
depression and anxiety among first-time mothers during pregnancy and the early 
postpartum period. In the first study, a measure of maternal attitudes, the Attitudes 
Toward Motherhood Scale (AToM) was developed and validated in a sample of first-time 
mothers. The AToM was found to have good internal reliability and convergent validity 
with general cognitive biases and an existing measure of maternal attitudes. Exploratory 
and confirmatory factor analyses determined that the measure comprises three correlated 
factors representing beliefs about others’ judgments, beliefs about maternal 
responsibility, and maternal role idealization. In the second study, we used the AToM to 
assess the relationship between maternal attitudes and other psychological variables 
among pregnant and postpartum first-time mothers. The factor structure of the measure 
was confirmed and found to be invariant across pregnant and postpartum subjects. 
Dysfunctional maternal attitudes predicted symptoms of depression and anxiety, and 
these attitudes had incremental predictive validity over general cognitive biases and 
interpersonal risk factors. Dysfunctional maternal attitudes were related to neuroticism 
but not to other personality factors. Overall, the results of these studies suggest that 
attitudes toward motherhood are related to psychological distress among first-time 
mothers during the transition to parenthood and may provide a useful means of 
identifying women who may benefit from intervention during pregnancy and the early 
postpartum period.  
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The Relationship Between Maternal Attitudes and Symptoms of Depression and Anxiety 
Among Pregnant and Postpartum First-Time Mothers 
Emotional distress during the perinatal period is one of the most common 
complications of childbearing. Approximately 10-15% of women experience a depressive 
episode during pregnancy or the first year postpartum (Bennett, Einarson, Taddio, Koren 
& Einarson, 2004; Joseffson, Berg, Nordin & Sydsjo, 2001). High levels of anxiety are 
also common during pregnancy (Lee, Lam, Lau, Cong, Chui, & Fong, 2007) and the first 
year postpartum (Stuart, Couser, Schilder, O’Hara, & Gorman, 1998; Wenzel, Haugen, 
Jackson, & Brendle, 2005).  
 Depression and anxiety during the perinatal period are associated with adverse 
fetal and child outcomes. Depression during pregnancy is associated with increased risk 
for preterm birth, low birth weight, and preeclampsia (Grote, Bridge, Gavin, Melville, 
Iyengar, & Katon, 2010; Kim, Sockol, Sammel, Kelly, Moseley, & Epperson, 2012). 
Postpartum depression is a risk factor for a range of adverse child outcomes, including 
behavioral problems and impaired cognitive development (Grace, Evindar, & Stewart, 
2003). Prenatal anxiety is also associated with poor birth outcomes (Littleton, Breitkopf, 
& Berenson, 2007), and maternal anxiety is a risk factor for behavioral and emotional 
maladjustment in children, even controlling for the effects of depressive symptoms 
(O’Conner, Heron, Glover, & the ALSPAC Study Team, 2002). Given the prevalence 
and potential consequences of perinatal depression and anxiety, research that helps 
clinicians and researchers effectively identify women at-risk for these disorders and 
develop effective interventions is vitally necessary.  
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 Epidemiological research has identified a wide range of risk factors for perinatal 
depression and anxiety. A personal or familial history of major depressive episodes is 
among the most potent predictors of perinatal depressive symptoms (Beck, 2001; O’Hara 
& Swain, 1996; Robertson, Grace, Wallington, & Stewart, 2004). Women of low 
socioeconomic status, ethnic/racial minorities, and single women are also at higher risk 
for perinatal depression and anxiety (Beck, 2001; Littleton, Breitkopf, & Berenson, 2007; 
O’Hara & Swain, 1996; Robertson, Grace, Wallington, & Stewart, 2004). While these 
risk factors can help clinicians and researchers identify women at-risk for distress during 
the transition to parenthood, many of these risk factors are challenging to modify. An 
important goal for research in this area is the identification of risk factors that can serve 
as targets for prevention and intervention.  
Beck’s cognitive model provides a conceptual framework that may guide us in the 
identification of vulnerability factors for depression and anxiety that could be targeted for 
intervention. According to this model, cognitive biases confer a vulnerability to 
symptoms of depression and anxiety in the context of potentially stressful life events 
(Beck, 1967; 1976; 1985). According to this model, the relationship between life events 
and emotional experiences is mediated by cognitive processes. Maladaptive emotional 
responses, such as depression and anxiety, result from biases in these cognitive processes. 
In depressed individuals, these biases are commonly characterized by a negative view of 
the self, world, and future (Beck, 1967; 1976). Among individuals with anxiety disorders, 
cognitions are frequently characterized by heightened perceptions of threat and danger 
(Beck, 1985). Previous research has demonstrated that negative cognitive biases are 
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associated with depression during pregnancy and the postpartum (Cutrona, 1983; Grazioli 
& Terry, 2000; Hull & Mendolia, 1991; O’Hara, Rehm, & Campbell, 1982). While this 
construct has received relatively less attention in relation to perinatal anxiety, cognitive 
biases are also associated with symptoms of anxiety among this population (Littleton, 
Breitkopf, & Berenson, 2007). Importantly, these biases can be targeted through 
psychological interventions, particularly cognitive-behavioral therapies (Appleby, 
Warner, Whitton, & Faragher, 1997; Cooper, Murray, Wilson, & Romaniuk, 2003). 
 While much research on cognitive vulnerability to depression and anxiety has 
focused on general negative biases, there is also evidence that specific types of cognitions 
may interact with particular stressors to produce maladaptive emotional responses. 
According to this “event congruency hypothesis,” an individual’s characteristic cognitive 
style may leave them differentially vulnerable to distress in the context of negative events 
that are congruent with the important components of their maladaptive schemas (Francis-
Raniere, Alloy, & Abramson, 2006; Segal, Shaw, Vella, & Katz, 1992). Most research in 
this area has investigated the role of self-criticism and dependency, two particular styles 
of negative cognition, in interaction with life events that are achievement- or 
interpersonally-oriented. Overall, the results of longitudinal research in this area suggest 
that individuals who have a self-critical cognitive style are particularly vulnerable to 
depressive episodes following achievement-oriented stressors, while individuals with a 
dependent cognitive style are particularly vulnerable to depressive episodes following 
interpersonally-oriented stressors (Hammen, Marks, Mayos, & deMayo, 1985; Hammen, 
Ellicott, Gitlin, & Jamison, 1989; Francis-Raniere, Alloy, & Abramson, 2006). 
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Interestingly, research among perinatal populations suggests that self-criticism is a risk 
factor for depressive symptoms, while dependency is not associated with increased risk 
for depression (Besser & Priel, 2003; Besser, Priel, Flett, & Wiznitzer, 2007).  
There is also evidence that the specific content of maladaptive cognitions may 
confer risk for psychopathology in the context of relevant stressors. For example, 
Schmidt, Lerew, and Jackson (1997) studied whether anxiety sensitivity, a hypothesized 
cognitive risk factor for panic disorder, predicted the occurrence of panic attacks among 
young adults enrolled in a five-week basic training program at the Air Force Academy. 
They found that anxiety sensitivity predicted the probability that recruits would 
experience a panic attack during this period, even controlling for a history of previous 
panic attacks. Hillman and Garber (1995) found that cognitions related to academic 
competence and academic self-control predicted negative affect and depressive 
symptoms among elementary-school children whose grades were lower than expected. 
Beliefs specifically related to academic competence and self-control had incremental 
predictive validity beyond the students’ general attributional style. These studies suggest 
that it may be possible to identify specific maladaptive beliefs that are conceptually 
related to potential stressors that place an individual at-risk for negative emotional 
responses.  
With regard to perinatal depression and anxiety, beliefs and attitudes about 
motherhood have the potential to function as a specific cognitive vulnerability. While 
cognitive biases are a general risk factor for depression and anxiety, attitudes toward 
motherhood may also mediate the relationship between the specific stressors women 
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experience during pregnancy and early parenthood and their emotional responses to these 
events. As such, maternal attitudes would represent an additional and more specific risk 
factor for symptoms of depression and anxiety among perinatal populations.  
There is evidence supporting an association between negative attitudes towards 
motherhood and depression during pregnancy and the first year postpartum. Women’s 
expectations of motherhood and attitudes toward role conflict predict subsequent 
depressive symptoms during pregnancy (Warner, Appleby, Whitton, & Faragher, 1997). 
Women’s attitudes toward performance-oriented elements of motherhood are predictive 
of later depressive symptoms (Grazioli & Terry, 2000). Women’s attitudes towards 
motherhood have also been found to mediate the relationship between parental stress and 
depressive symptoms (Church, Brechman-Toussaint, & Hine, 2005). Dysfunctional 
maternal attitudes predict concurrent levels of depressive symptoms during pregnancy 
and the early postpartum period, and changes in maternal attitudes from pregnancy 
through six weeks postpartum predict depressive symptoms at six weeks postpartum, 
even controlling for prior depressive symptoms (Sockol, 2008).  
While maternal attitudes appear promising as a means of identifying women at-
risk for perinatal depression and anxiety and as a target for intervention, research in this 
area has been limited by the lack of an adequate measure of this construct. Several 
measures designed for use by women during pregnancy emphasize women’s expectations 
of parenthood (Belsky, 1985; Harwood, 2004; Kalmuss, Davidson, & Cushman, 1992). 
However, given that pregnancy and parenthood are inherently periods of increased stress, 
negative expectations may not only be accurate, but may serve a protective function. 
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Women tend to have overly negative expectations of parenthood, but these negative 
expectations do not predict psychological maladjustment – rather, women whose actual 
experiences are more negative than their expectations are at increased risk for postpartum 
depressive symptoms (Harwood, 2004). Other measures of maternal attitudes likewise 
confound attitudes toward motherhood with women’s experiences of pregnancy and 
parenting (DiPietro, Ghera, Costigan, & Hawkins, 2004; Kumar, Robson, & Smith, 1984; 
Warner, Appleby, Whitton, & Faragher, 1997). The cognitive models of depression and 
anxiety emphasize the role of individuals’ beliefs in the interpretation of the events they 
experience, thus it is important that assessments of cognitive biases are careful to 
distinguish between appraisals of life events and the events themselves. 
In addition to conceptual limitations of existing measures of maternal attitudes, 
our previous research has identified psychometric problems with a commonly used 
measure of this construct. Specifically, in a previous study of the role of maternal 
attitudes in predicting perinatal depressive symptoms, we found that the Maternal 
Attitudes Questionnaire (Warner, Appleby, Whitton, & Faragher, 1997) had poor internal 
reliability, particularly among subjects who were pregnant with their first child (Sockol, 
2008). Examination of the content of the measure reveals items, such as “Having a baby 
has made me as happy as I expected,” that may be confusing or inappropriate for 
primiparous pregnant women.  Given these limitations, the development of a valid and 
reliable measure of maternal attitudes is necessary for further research assessing their role 
as a potential risk factor for perinatal depression and anxiety.  
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 The overarching goal of the present research was to develop a measure of 
maternal attitudes appropriate for use with first-time mothers, both pregnant and 
postpartum, and to use this measure to assess the relationship between maternal attitudes 
and emotional distress. We hypothesized that dysfunctional maternal attitudes would 
predict symptoms of depression and anxiety and have incremental predictive validity 
over and beyond general cognitive biases and interpersonal risk factors.  
Study 1 
 The goal of Study 1 was to validate a self-report measure of maternal attitudes in 
a sample of first-time mothers. We conducted exploratory and confirmatory factor 
analyses to assess the psychometric properties of the measure. We expected that attitudes 
toward motherhood would comprise several factors reflecting specific types of beliefs 
related to motherhood. We tested the convergent validity of the Attitudes Toward 
Motherhood Scale (AToM) with a measure of general cognitive biases (the Dysfunctional 
Attitudes Scale, DAS; Weissman & Beck, 1978) and an existing but flawed measure of 
maternal attitudes (the Maternal Attitudes Questionnaire, MAQ; Warner, Appleby, 
Whitton, & Faragher, 1997). We expected that maternal attitudes as measured by the 
AToM and MAQ would correlate strongly with one another and that participants’ scores 
on the AToM would also be strongly related to general cognitive biases. Furthermore, we 
expected the AToM to have superior reliability to the MAQ, particularly among pregnant 
participants.  
Method 
Participants and procedures.  
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Participants for this study were recruited online via social media through sites 
such as Facebook, Twitter, and online forums for women who are pregnant or parenting 
(e.g., CafeMom). Specifically, an invitation to participate in a “study of the way women 
think about motherhood” and a link to an online survey was posted on these sites in the 
spring of 2011. The survey site included an online consent form followed by eligibility 
questions, a series of self-report questionnaires and, finally, questions about demographic 
variables. Participants were compensated via a raffle for $150.  
Two hundred thirty-four women initiated participation in the study. Women were 
eligible to participate if they were between the ages of 18 and 45, resided in the United 
States, and were either pregnant with their first child (between 13 and 40 weeks 
gestational age) or had given birth to their first child within the previous 6 months. Three 
subjects were excluded because they were under age 18, 14 subjects were excluded 
because they were not pregnant or within six months of giving birth to their first child, 
and 7 subjects were excluded because they did not reside in the United States. Of the 210 
women who were eligible to participate, 65% (n = 136) women completed at least one 
measure and 50% (n = 104) completed all study measures. We compared women who 
dropped out at each stage of the study to women who completed the measures; there were 
no differences between dropouts and completers on any measure.   
Demographic characteristics of the sample are presented in Table 1. About 59% 
of subjects were currently pregnant with their first child (n = 80) and 41% (n = 56) had 
given birth to their child within the past 6 months. For pregnant subjects, the mean 
gestational age was 26.1 weeks (SD = 8.3 weeks, range 13-40 weeks). The mean age of 
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postpartum subjects’ children was 12.5 weeks (SD = 8.2 weeks, range 1-24 weeks). The 
sample was predominantly married (65%) and Caucasian (78%) and represented a wide 
range of socioeconomic backgrounds.   
Measures. 
 Development of the Attitudes Toward Motherhood Scale. We began by 
generating a pool of 62 items reflecting attitudes toward motherhood. Some items were 
derived by modifying measures of general cognitive biases to reflect content specific to 
motherhood (e.g., “Making mistakes caring for my baby is fine because I can learn from 
them” was modified from the DAS item “Making mistakes is fine because I can learn 
from them,” Weissman & Beck, 1978). We also modified items from a measure of 
women’s expectations of motherhood to reflect beliefs, rather than expectations (e.g., “I 
should not have difficulty becoming comfortable caring for my baby” was modified from 
the Parenting Expectations Measure item “I will not have difficulty becoming 
comfortable caring for my baby,” Harwood, 2004). Additional items were derived from a 
manual of cognitive-behavioral therapy for postpartum depression which listed common 
maladaptive beliefs expressed by these women (e.g., “Now that I am a mother, my past 
lifestyle and activities should not be important,” Olioff, 1991) and from interviews with 
women who were pregnant or mothers of children under the age of two years (e.g., “I feel 
guilty about wanting to do the things I did before I became pregnant”). The set of items 
proposed for inclusion in the measure was reviewed by a small group of graduate 
students in clinical psychology who are familiar with the cognitive models of depression 
and anxiety disorders. Their comments regarding item clarity and wording and additional 
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suggested items were used to modify the item pool. Finally, the measure was piloted 
online with a small group of women recruited separately from those in the present study. 
These women were asked to provide qualitative feedback after completing the measure; 
these responses were used to refine the measure and to generate additional items.  
 Dysfunctional Attitudes Scale. General cognitive biases were assessed with the 
short form of the Dysfunctional Attitude Scale (DAS), a 40-question self-report measure 
designed to assess the various assumptions and beliefs posited by Beck (1967, 1976) to 
underlie psychological maladjustment (Weissman & Beck, 1978). Subjects were asked to 
rate, on a 7-point Likert scale, the degree to which they agree with statements of beliefs or 
attitudes (e.g., “If I do not do well all the time, people will not respect me”). Higher scores 
reflect more maladaptive cognitions. Cronbach’s alpha in the sample was 0.91 and was 
comparable for the pregnant (α = 0.90) and postpartum (α = 0.90) samples.  
 Maternal Attitudes Questionnaire. Participants also completed an existing measure 
of maternal attitudes, the Maternal Attitudes Questionnaire (MAQ; Warner et al., 1997). 
This is a 14-question self-report measure that assesses cognitions in three domains: 
expectations of motherhood, expectations of the self as a mother, and role conflict (e.g., “I 
think my baby is very demanding”). Higher scores are indicative of more maladaptive 
cognitions. As in our previous research, internal reliability for the measure was low (α = 
0.63), especially among pregnant participants (α = 0.57, postpartum sample α = 0.64).  
Results and Discussion 
 Of the original 62 items considered for inclusion in the AToM, we initially 
retained 50% of items representing items with the greatest variance. We then conducted 
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an exploratory factor analysis on the remaining 31 items. We used several means of 
assessing the optimal number of factors: Cattell’s (1966) scree test, Bartlett’s chi-square 
test (Geweke & Singleton, 1980), parallel analysis (Horn, 1965), and the minimum 
average partial criterion (Velicer, 1976). These tests all suggested the optimal factor 
solution would contain 2-4 factors, with a modal solution of 3 factors. We assessed the 2-
, 3-, and 4-factor structures for conceptual clarity of extracted factors and the best 
approximation of simple structure. A three-factor structure with promax rotation satisfied 
these criteria. An oblique factor rotation was used because the factors were assumed to 
correlate with one another. Factor analysis was also conducted using an orthogonal 
(varimax) rotation; the three-factor structure was replicated with this rotation (results not 
shown).  
The initial factor solution produced a 3-factor structure with 6-8 items loading on 
each factor, for a total of 21 items. Each of these factors was then examined for 
redundancy and item clarity. To reduce subject burden, we eliminated items with the 
lowest factor loadings. Items with factor loadings < 0.60 were eliminated. See Table 2 for 
the 12 retained items. The first factor contains four items that reflect beliefs related to 
others’ judgments, the second factor contains four items reflecting beliefs related to 
maternal responsibility, and the third factor contains four items reflecting beliefs related 
to maternal role idealization. Cronbach’s alpha in the full sample was 0.81 and was 
comparable for the pregnant (α = 0.82) and postpartum (α = 0.79) samples.  
To test the integrity of the final three-factor solution, we used confirmatory factor 
analysis to assess the overall fit of the three-factor model and to compare the three-factor 
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model to a one-factor model. The three-factor model demonstrated good fit to the data , 
χ2(51) = 83.3, p < 0.01, SRMR = 0.08, CFI = 0.95, RMSEA = 0.07, p > 0.05. Comparison 
of the three-factor solution to a one-factor solution indicated that the three-factor solution 
was a significantly better fit to the data, χ2(3) = 233.81, p < 0.001.  
Descriptive statistics for the study measures and intercorrelations among the 
measures are presented in Table 3. We assessed the convergent validity of the AToM 
using the DAS and MAQ. Due to the low reliability of the MAQ, we corrected the 
correlations among the measures for attenuation according to Block’s (1963) method. 
The AToM was significantly correlated with both general cognitive biases (r = 0.50 after 
correction for attenuation) and maternal attitudes as assessed by the MAQ (r = 0.43 after 
correction for attenuation), with magnitudes in the medium range. The MAQ was also 
significantly correlated with general cognitive biases (r = 0.34 after correction for 
attenuation). Meng, Rosenthal, and Rubin’s (1992) approach for comparing the 
magnitude of correlation coefficients was used to assess the difference between these 
correlations; there were no significant differences in the magnitude of the strength of the 
relationships among the three variables.  
We assessed the convergent validity of the three subscales of the AToM using the 
same approach. Factor 1 of the AToM, comprising beliefs related to others’ judgments, 
was moderately associated with Factor 3 of the AToM (comprising beliefs related to 
maternal role idealization) and with the MAQ, and was strongly associated with general 
cognitive biases. Factor 2 of the AToM, comprising beliefs related to maternal 
responsibility, was not associated with Factor 1 of the AToM, general cognitive biases, or 
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the MAQ, but was strongly associated with Factor 3 of the AToM. Factor 3 of the AToM, 
comprising beliefs related to maternal role idealization, was moderately associated with 
Factor 1 of the AToM, general cognitive biases, and the MAQ, and was strongly 
associated with Factor 2 of the AToM.  
Results of these analyses support our hypothesis that dysfunctional maternal 
attitudes, as assessed using the AToM, are associated with general cognitive biases. We 
also demonstrated that our measure has good convergent validity with an existing, but 
problematic, measure of maternal attitudes. We did not find that dysfunctional maternal 
attitudes, as assessed by the AToM and MAQ, were related more strongly to one another 
than to general cognitive biases.  
The pattern of correlations observed among the subscales of the AToM and the 
MAQ and DAS suggest that beliefs related to maternal responsibility represent a distinct 
facet of attitudes toward motherhood that, while related to maternal role idealization, are 
distinct from general patterns of negative cognitive biases and other elements of maternal 
attitudes. Beliefs related to others’ judgments appear most strongly related to general 
cognitive biases, while beliefs related to maternal role idealization are only moderately 
related to these general cognitive biases. The patterns of correlations observed among the 
subscales of the measure suggest that, while the maternal attitudes assessed by the AToM 
are related to general cognitive biases, they represent a separate construct. 
Study 2 
 The goal of Study 2 was to use the AToM to assess the relationship between 
maternal attitudes and psychological variables among first-time mothers during the 
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transition to parenthood. We hypothesized that dysfunctional maternal attitudes would 
predict symptoms of depression and anxiety among pregnant and postpartum first-time 
mothers and that these attitudes would have incremental predictive validity over general 
cognitive biases and interpersonal risk factors for depression and anxiety. We also 
assessed the discriminant validity of the measure by assessing the relationship between 
maternal attitudes and a broad range of psychological symptoms, as assessed by the Brief 
Symptom Inventory (Derogatis & Spencer, 1982), and personality factors, as assessed by 
the Big Five Inventory (John, Naumann, & Soto, 2008). We predicted that dysfunctional 
maternal attitudes would be most strongly related to psychological symptoms that are 
closely related to depression and anxiety (e.g., obsessiveness) and less strongly related to 
other psychological symptoms (e.g., psychoticism and paranoia). We predicted that 
dysfunctional maternal attitudes would be strongly related to neuroticism, but would be 
less strongly associated with other personality factors.  
Method 
Participants and procedures. 
 Participants for this study were recruited in the spring of 2012 through the same 
social media sites as for Study 1. The survey site included an online consent form 
followed by eligibility questions, a series of self-report questionnaires and, finally, 
questions about demographic variables. Participants were compensated by a raffle for 
$150. 
Three hundred and eighty-three women initiated participation in the study. 
Women were eligible to participate if they were between the ages of 18 and 45, resided in 
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the United States, and were either pregnant with their first child (between 13 and 40 
weeks gestational age) or had given birth to their first child within the previous 6 months. 
Four subjects were excluded because they were under age 18 or over age 45, 29 subjects 
were excluded because they were not pregnant or within six months of giving birth to 
their first child, and 11 subjects were excluded because they did not reside in the United 
States. Of the 339 women who were eligible to participate, 85% (n = 288) completed at 
least one measure and 62% (n = 211) completed all study measures. We compared 
subjects who completed each measure to subjects who dropped out at each stage of the 
study. Subjects who dropped out prior to completing the DAS had significantly higher 
AToM scores than subjects who completed the DAS; subjects who dropped out prior to 
completing the DYAD had significantly higher AToM and STAI scores than those who 
completed the DYAD, and subjects who dropped out prior to completing the MDPSS had 
significantly higher AToM and DYAD scores than those who completed the MDPSS. 
Overall, the results of these analyses suggest that subjects at higher risk for psychological 
difficulties were more likely to drop out of the study prior to completion of all measures.  
Demographic characteristics of the sample are presented in Table 1. About 43% 
of subjects were currently pregnant with their first child (n = 145), and 57% (n = 195) 
had given birth to their child within the previous 6 month period. For pregnant subjects, 
the mean gestational age was 24.1 weeks (SD = 7.2 weeks, range 12-39 weeks). The 
mean age of postpartum subjects’ children was 13.9 weeks (SD = 7.0 weeks, range 1-24 
weeks). The sample was predominantly married (79.5%) and Caucasian (94%). The 
sample was highly educated and relatively affluent: 44.5% of subjects had a 
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graduate/professional degree, 29.8% of subjects reported annual household incomes 
greater than $100,000, and 51.6% of subjects reported that they were employed full-time.  
Measures. 
Cognitive risk factors. Attitudes toward motherhood were assessed using the 
Attitudes Towards Motherhood Scale (AToM), described in Study 1. Cronbach’s alpha 
for the scale was 0.86. General cognitive biases were assessed using the Dysfunctional 
Attitudes Scale (DAS); to reduce subject burden we utilized the 17-item version (de 
Graaf, Roelofs, & Huibers, 2009). Cronbach’s alpha for the scale was 0.92.   
 Interpersonal risk factors. Subjects who were married or in a committed 
relationship completed the Dyadic Adjustment Scale (DYAD; Spanier, 1976), a 32-item 
measure of relationship satisfaction. Cronbach’s alpha for the scale was 0.93. All subjects 
completed the Multidimensionalal Scale of Perceived Social Support (MDPSS; Zimet, 
Dahlem, Zimet, & Farley, 1988), which assesses satisfaction with perceived social support 
from partners, family, and friends. Cronbach’s alpha for the scale was 0.94. As subjects’ 
scores on the MDPSS were non-normally distributed, the variable was square-root 
transformed prior to analyses.  
 Psychological symptoms. Depressive symptoms were assessed using the Edinburgh 
Post-Natal Depression Scale (EPDS; Cox, Holden, & Sagovsky, 1987). This 10-item 
measure was developed for use by pregnant and postpartum women; the scale takes into 
account normative experiences of perinatal women that correspond with diagnostic criteria 
for depression (e.g., weight change and fatigue) that can bias other measures of depressive 
symptoms. Scores greater than or equal to 12 are indicative of a possible depressive episode 
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(Cox et al., 1996). Cronbach’s alpha for the scale was 0.87. Syptoms of anxiety were 
assessed using the State-Trait Anxiety Inventory (STAI; Spielberger, 1983), a 40-item 
measure that assesses current symptoms of anxiety and subjects’ global tendency toward 
trait anxiety. Cronbach’s alpha for both the state and trait subscales of the STAI was 0.94.  
As the two subscales of the STAI were highly correlated (r = 0.80), a composite STAI score 
was calculated and used as the outcome variable for all analyses; Cronbach’s alpha for the 
composite scale was 0.96.  
 Global symptoms of psychological distress were assessed using the Brief Symptom 
Inventory (BSI; Derogatis & Spencer, 1982), a 53-item measure of psychological symptoms 
that reflects nine domains of problems (somatization, obsessiveness, interpersonal 
sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, and 
psychoticism). Cronbach’s alpha for the subscales of the BSI ranged from 0.71 to 0.87.  
Because the distribution of scores on the BSI subscales was non-normal, the subscales were 
coded into dichotomous variables for all analyses. Subjects who rated any item on a 
subscale as “quite a bit” or “extremely” distressing received a score of 1, while subjects who 
rated all items as “moderately” distressing or lower received a score of 0.  
 Personality. Personality was assessed using the Big Five Inventory (BFI; John, 
Naumann, & Soto, 2008), a 44-item measure that asesses five domains of personality 
structure (openness to experience, conscientiousness, extraversion, agreeableness, and 
neuroticism). Cronbach’s alpha for the subscales of the BFI ranged from 0.76 to 0.88.  
Results and Discussion 
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 Descriptive statistics for the primary study measures and intercorrelations among 
the measures are presented in Table 4. As expected, cognitive risk factors, interpersonal 
risk factors, and psychological symptoms were moderately to highly correlated. The 
AToM was most highly correlated with the DAS (r = 0.50), followed by symptoms of 
depression (r = 0.41) and anxiety (r = 0.41). Meng, Rosenthal, and Rubin’s (1992) 
approach for comparing the magnitude of correlation coefficients was used to assess the 
difference between these correlations; there was a trend for the AToM to be more 
strongly associated with the DAS than with the EPDS (p = 0.06) and the STAI (p = 0.06). 
The correlations between the AToM and measures of interpersonal risk, including the 
DYAD (r  = -0.15) and the MDPSS (r = 0.20) were significantly smaller than the 
correlations between the AToM and the DAS and psychological symptoms (all p values < 
0.001).  
In contrast to the results of Study 1, each of the three subscales of the AToM was 
moderately to strongly correlated with the other subscales. Factor 2 of the AToM was 
also moderately associated with general cognitive biases in this sample, although the 
magnitude of this association was smaller than for Factors 1 and 3. All three factors of 
the AToM correlated moderately to highly with general cognitive biases and symptoms 
of depression and anxiety. Factors 1 and 2 of the AToM were weakly correlated with 
inadequate social support, and Factor 1 of the AToM was weakly associated with low 
marital satisfaction. Factors 2 and 3 of the AToM were not associated with marital 
satisfaction, and Factor 3 was not associated with inadequate social support.  
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As expected, psychological symptoms were strongly correlated with one another, 
Marital satisfaction and social support were moderately correlated with one another.  
Factor structure of the AToM.  
To assess the stability of the factor structure of the AToM identified in Study 1, 
confirmatory factor analysis was use to assess the fit of the original three-factor model 
and to compare this model to a one-factor model. The three-factor model was a 
marginally acceptable fit to the data , χ2(51) = 202.8, p < 0.001, SRMR = 0.10, CFI = 
0.89, RMSEA = 0.10, p < 0.001. Comparison of the three-factor solution to a one-factor 
solution indicated that the three-factor solution was a significantly better fit to the data, 
χ2(3) = 346.8, p < 0.001.  
We also assessed whether the factor structure of the AToM was comparable for 
pregnant and postpartum subjects. We first specified a model in which the factor loadings 
and factor covariances were allowed to vary freely between the two groups. We then 
specified a model in which factor loadings were constrained to be equal between the two 
groups. There was not a significant difference in the fit of the constrained model χ2(12) = 
16.48, p > 0.05, and the change in the CFI was less than 0.01 (ΔCFI = 0.003), which 
indicates that the constrained model has comparable model fit (Cheung & Rensvold, 
2002). We then specified a model in which both the factor loadings and the factor 
correlations were constrained to be equal between the two groups. There was not a 
significant difference in the fit of the constrained model, χ2(3) = 6.82, p > 0.05, and the 
change in the CFI was less than 0.01 (ΔCFI = 0.003), which indicates that the constrained 
model has comparable model fit (Cheung & Rensvold, 2002). Results of these analyses 
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suggest that the factor structure of the AToM and the correlations among the factors are 
comparable for pregnant and postpartum subjects.  
Convergent and predictive validity of the AToM. 
We conducted a series of multiple regression models to assess the convergent and 
predictive validity of the AToM (see Table 5). In Model 1, we assessed the convergent 
validity of maternal attitudes (as assessed by the AToM) with general cognitive biases (as 
assessed by the DAS). After controlling for demographic variables, dysfunctional 
maternal attitudes significantly predicted general cognitive biases (β = 0.50). The 
predictive validity of maternal attitudes was assessed using depressive symptoms (Model 
2, as assessed by the EPDS) and anxiety symptoms (Model 3, as assessed by the STAI 
composite) as outcome measures. After controlling for demographic variables, 
dysfunctional maternal attitudes were a significant predictor of both depressive symptoms 
(β = 0.43) and anxiety symptoms (β = 0.43).  
We then conducted a series of multiple regression models to assess the convergent 
and predictive validity of the subscales of the AToM (see Table 5). In Model 4, we 
assessed the convergent validity of the three subscales with general cognitive biases (as 
assessed by the DAS). After controlling for demographic variables, only beliefs related to 
others’ judgments (AToM Factor 1) predicted general cognitive biases. The predictive 
validity of the three subscales was assessed using depressive symptoms (Model 5, as 
assessed by the EPDS) and anxiety symptoms (Model 6, as assessed by the STAI 
composite) as outcome measures. After controlling for demographic variables, beliefs 
related to others’ judgments (AToM Factor 1) and beliefs related to maternal 
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responsibility (AToM Factor 2) were significantly associated with depressive symptoms. 
Only beliefs related to others’ judgments (AToM Factor 1) were significantly associated 
with anxiety symptoms.  
A series of multiple regressions were conducted to assess the incremental 
predictive validity of maternal attitudes as compared to general cognitive biases and 
interpersonal risk factors (marital satisfaction, as assessed by the DYAD, and inadequate 
social support, as assessed by the MDPSS, see Table 6). We first conducted hierarchical 
multiple regressions in which demographic variables were entered in Step 1, cognitive 
biases were added in Step 2, and maternal attitudes were added in Step 3. Separate 
regressions were conducted for depressive symptoms (Model 1) and anxiety symptoms 
(Model 4). After controlling for demographic variables and general cognitive biases, the 
AToM was a significant predictor of both depressive symptoms (β = 0.24) and anxiety 
symptoms (β = 0.18). We then conducted hierarchical multiple regressions in which 
demographic variables were entered in Step 1, interpersonal risk factors were entered in 
Step 2, cognitive biases were entered in Step 3, and maternal attitudes were entered in 
step 4. Separate regressions were conducted for depressive symptoms (Model 2) and 
anxiety symptoms (Model 5). After controlling for demographic variables, interpersonal 
risk factors, and cognitive biases, dysfunctional maternal attitudes were significant 
predictors of both depressive symptoms (β = 0.15) and anxiety symptoms (β =0.18). In 
order to assess the relative contributions of interpersonal and cognitive risk factors, we 
then conducted hierarchical multiple regressions in which demographic variables were 
entered in Step 1, maternal attitudes were entered in Step 2, cognitive biases were entered 
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in Step 3, and interpersonal risk factors were entered in Step 4. Separate regressions were 
conducted for depressive symptoms (Model 5) and anxiety symptoms (Model 6). Both 
inadequate social support and marital satisfaction were significant predictors of 
symptoms of depression (βMDPSS  = 0.23, βDYAD  = -0.17) and anxiety (βMDPSS  = 0.27, 
βDYAD  = -0.19), after controlling for maternal attitudes and general cognitive biases.  
We also conducted a series of multiple regressions were conducted to assess the 
incremental predictive validity of the three subscales as compared to general cognitive 
biases and interpersonal risk factors (marital satisfaction, as assessed by the DYAD, and 
inadequate social support, as assessed by the MDPSS) (see Table 7). We first conducted 
hierarchical multiple regressions in which demographic variables were entered in Step 1, 
cognitive biases were added in Step 2, and the three subscales of the AToM were added 
in Step 3. Separate regressions were conducted for depressive symptoms (Model 1) and 
anxiety symptoms (Model 4). After controlling for demographic variables and general 
cognitive biases, beliefs related to others’ judgments (AToM Factor 1) and beliefs related 
to maternal responsibility (AToM Factor 2) were significantly associated with symptoms 
of depression. Only beliefs related to others’ judgments (AToM Factor 1) were 
significantly associated with symptoms of anxiety.  
We then conducted hierarchical multiple regressions in which demographic 
variables were entered in Step 1, interpersonal risk factors were entered in Step 2, 
cognitive biases were entered in Step 3, and maternal attitudes were entered in Step 4. 
Separate regressions were conducted for depressive symptoms (Model 2) and anxiety 
symptoms (Model 5). After controlling for demographic variables, interpersonal risk 
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factors, and cognitive biases, each of the subscales of the AToM was significantly 
associated with symptoms of depression, while only beliefs related to others’ judgments 
(AToM Factor 1) were significantly associated with symptoms of anxiety. 
In order to assess the relative contributions of interpersonal and cognitive risk factors, we 
then conducted hierarchical multiple regressions in which demographic variables were 
entered in Step 1, maternal attitudes were entered in Step 2, cognitive biases were entered 
in Step 3, and interpersonal risk factors were entered in Step 4. Separate regressions were 
conducted for depressive symptoms (Model 5) and anxiety symptoms (Model 6). Both 
inadequate social support and marital satisfaction were significant predictors of 
symptoms of depression and anxiety after controlling for demographic variables and 
cognitive biases. This suggests that both interpersonal and cognitive factors are uniquely 
associated with perinatal distress.  
Discriminant validity. 
To assess the discriminant validity of the AToM, a series of multiple regressions 
was conducted to assess the relationship between the AToM and psychological 
symptoms, as assessed by the BSI, and personality factors, as assessed by the BFI. The 
total AToM score and each subscale of the AToM were assessed as outcomes in separate 
regressions, and demographic variables and each of the subscales of the measure (BSI or 
BFI) were entered into the model simultaneously. Of the nine subscales of the BSI, only 
obsessiveness and hostility were significantly associated with overall dysfunctional 
maternal attitudes after controlling for demographic variables and the other subscales of 
the BSI (see Table 8). After controlling for demographic variables and the other subscales 
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of the BSI, obsessiveness was significantly associated with all three subscales of the 
AToM (see Table 8). Hostility was significantly associated with beliefs related to others’ 
judgments (AToM Factor 1) and beliefs related to maternal responsibility (AToM  Factor 
2). Paranoia was significantly associated with beliefs related to maternal responsibility 
(AToM Factor 2).  
Of the five personality factors assessed by the BFI, only neuroticism was 
significantly associated with overall dysfunctional maternal attitudes after controlling for 
demographic variables and other personality factors (see Table 9). After controlling for 
demographic variables and the other subscales of the BFI, neuroticism and extraversion 
were associated with beliefs related to others’ judgments (AToM Factor 1); no other 
subscales of the BFI were related to other subscales of the AToM (see Table 9). 
General Discussion 
 The results of these studies suggest that dysfunctional attitudes toward 
motherhood are a specific predictor of symptoms of depression and anxiety during the 
transition to parenthood, even when known risk factors are controlled. In Study 1, we 
developed a measure of maternal attitudes that is appropriate for use among first-time 
mothers. We demonstrated that the measure has good convergent validity with general 
cognitive biases and an existing but flawed measure of maternal attitudes. In Study 2, we 
used this measure to assess the relationship between maternal attitudes and psychological 
symptoms among pregnant and postpartum first-time mothers. Dysfunctional maternal 
attitudes were strongly predictive of both depression and anxiety and demonstrated 
incremental predictive validity over and beyond general cognitive biases and 
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interpersonal risk factors for these symptoms. Dysfunctional maternal attitudes were 
associated with neuroticism, the dimension of personality that is most strongly associated 
with depression and anxiety (Kotov, Gamez, Schmidt & Watson, 2010), but were not 
associated with other personality factors.  
Our findings are consistent with the results of other studies assessing risk factors 
for perinatal distress. Reviews of research in this area have consistently found that both 
cognitive and interpersonal factors have moderate to large associations with depressive 
symptoms (Beck, 2001; O’Hara & Swain, 1996; Robertson et al., 2004). We found that 
both cognitive and interpersonal risk factors have unique predictive validity for 
symptoms of depression and anxiety, even when other risk factors are controlled for. The 
results of these studies build upon this previous literature by demonstrating that a risk 
factor specific to the perinatal period, maternal attitudes, has incremental predictive 
validity above and beyond these established risk factors.  
 The results of this study are consistent with Beck’s (1967) cognitive model of 
psychopathology, which posits that psychological symptoms occur when maladaptive 
beliefs are activated in the context of a relevant stressor. Given the inherently stressful 
nature of pregnancy and new motherhood, this model would predict that women with 
maladaptive beliefs about motherhood would be at increased risk for depression and 
anxiety. While general maladaptive beliefs may also be activated by stressful events 
during this time, specific beliefs about motherhood may be most strongly activated by the 
particular stressors of pregnancy and parenting. For example, consider the following 
subject from the current study: This woman is currently 16 weeks pregnant with her first 
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child. Her EPDS score of 5 is in the nondepressed range, and her DAS score of 33 is in 
the 16
th
 percentile for our sample. However, her AToM score of 56 places her in the 95
th
 
percentile for our sample. This subject reported that she “almost always” believes “If I 
love my baby, I should want to be with him/her all the time.” This subject’s generally low 
level of overall cognitive biases may be protective against depression in the context of 
other life stressors. However, it is likely that during the postpartum period she will have 
the experience of wanting to spend some time away from her baby. Because of her 
specific attitudes toward motherhood, she may interpret this desire to mean that she does 
not love her child enough, and may then interpret this belief to mean that she is a bad 
mother. These beliefs may then lead to symptoms of depression, including feelings of 
sadness, guilt and worthlessness.   
 A major limitation of the current studies is their cross-sectional design. As risk 
factors and psychological symptoms were assessed simultaneously, it is impossible to 
establish whether dysfunctional maternal attitudes contributed causally to the 
development of these symptoms or whether they simply reflect the presence of 
depression and anxiety. Future research is necessary to establish whether these 
maladaptive beliefs precede the development of symptoms. To address this concern, a 
follow-up to the current study is planned in which the pregnant subjects will be contacted 
at 12 weeks postpartum. This will allow us to assess whether maternal attitudes during 
pregnancy predict changes in symptoms of depression and anxiety during the postpartum 
period.  
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Another limitation of the current studies was the homogeneity of our subjects. 
Participants in these studies were more likely to be white, highly-educated, affluent and 
married. The lack of sociodemographic diversity is a demonstrated problem in healthcare 
research (Woodall, Morgan, Sloan & Howard 2010). This is particularly relevant to the 
current research, as several studies have suggested that different factors may be 
predictive of depression and anxiety among ethnic minorities, women of low 
socioeconomic status, and women without a partner (e.g. Halbreich, 2005; Logsdon & 
Usui, 2001; Seguin, Potvin, St. Denis & Loiselle, 1995; Surkan, Peterson, Hughes & 
Gottlieb, 2006). We did not find that demographic characteristics were associated with 
psychological symptoms in our sample, but our ability to detect potential differences may 
have been limited by the relatively small numbers of single women, racial/ethnic 
minorities, and women of low socioeconomic status who participated in these studies. 
Further efforts to increase the diversity of participants in this research are necessary in 
order to determine whether maternal attitudes are related to demographic characteristics 
and whether the role of maternal attitudes may differ among women of different 
backgrounds.   
 The association between dysfunctional maternal attitudes and perinatal distress 
may provide clinicians with a means of detecting women at-risk for perinatal depression 
and anxiety. There is some evidence that there is a subgroup of women who are 
particularly vulnerable to perinatal depressive episodes (Bloch, Schmidt, Danaceau, 
Murphy, Nieman, & Rubinow, 2000; Cooper & Murray, 1995). By identifying women 
whose beliefs about motherhood may put them at risk for psychological distress during 
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pregnancy and the postpartum period, clinicians may be able to intervene early to prevent 
symptoms from occurring or reduce their severity or duration. A wide range of preventive 
interventions have been found to effectively reduce the prevalence of depressive episodes 
during the postpartum period (Sockol, 2012); women with maladaptive beliefs about 
motherhood may be likely to benefit from these interventions.  
 Our findings may also prove useful for clinicians and researchers interested in 
developing interventions for perinatal depression and anxiety, particularly cognitive-
behavioral interventions. There is some evidence that cognitive-behavioral therapy may 
not be as effective for perinatal depression as interpersonal psychotherapy (Sockol, 
Epperson, & Barber, 2011). However, researchers have developed a manualized version 
of interpersonal psychotherapy specific to perinatal depression that takes into account 
common interpersonal challenges that women face during the transition to parenthood 
(O’Hara, Stuart, Gorman, & Wenzel, 2000). Our findings provide evidence for themes 
that may characterize depressed women’s beliefs about motherhood. While cognitive-
behavioral therapy is inherently sensitive to individuals’ particular cognitive biases, 
developing specific interventions for perinatal populations that incorporate common 
cognitive distortions could lead to improved efficacy of cognitive-behavioral 
interventions for this population.  
 Overall, the results of these studies suggest that dysfunctional maternal attitudes 
are strongly associated with psychological symptoms during the perinatal period. While 
dysfunctional maternal attitudes are strongly associated with general cognitive biases, 
they have incremental predictive validity over these more general beliefs. Moreover, 
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dysfunctional maternal attitudes continue to predict symptoms of depression and anxiety 
even controlling for interpersonal factors. These findings are consistent with Beck’s 
cognitive model of psychopathology. Results of these studies suggest that maladaptive 
attitudes toward motherhood are a specific risk factor for perinatal depression and anxiety 
that may be used by clinicians and researchers to identify women at-risk for these 
disorders and as targets for intervention and prevention. Although further research is 
necessary to establish the causal role of these attitudes in the development of 
psychological symptoms and to assess whether these beliefs play a similar role among 
more diverse populations, these findings indicate that maternal attitudes play an 
important role in perinatal depression and anxiety.  
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Table 1 
Demographic Characteristics of Samples in Studies 1 and 2 
 Study 1 Study 2 
Age, M (SD) 28.3(4.7) 29.2 (4.8) 
Gestational Age (weeks), M (SD) 26.1 (8.3) 24.1 (7.2) 
Infant Age (weeks), M (SD) 12.5 (8.2) 13.9 (7.0) 
Relationship Status   
Married 65% 80% 
In a relationship, living together 13% 13% 
In a relationship, not living together 2% 1% 
Other 2% 6% 
Race/Ethnicity   
Asian/Pacific Islander 3% 1% 
Black/African-American 1% 4% 
Caucasian 78% 94% 
Latina 2% 5% 
Annual Household Income   
< $25,000 16% 11% 
$25,000-$49,999 18% 21% 
$50,000-$74,999 18% 21% 
$75,000-$99,999 12% 17% 
> $100,000 18% 30% 
Employment Status   
Full-Time 30% 52% 
Part-Time 15% 16% 
Unemployed 29% 23% 
Highest Level of Education   
Did Not Complete High School 1% 0% 
High School Diploma/GED 3% 7% 
Some College 19% 13% 
Associate’s Degree/Trade School 4% 6% 
Bachelor’s Degree 32% 29% 
Graduate or Professional Degree 24% 44% 
 
  
55 
 
Table 2 
Common Factor Analysis of Attitudes Toward Motherhood Scale with Promax Rotation 
in Study 1 
Factor Promax loading Item-total r 
Beliefs Related to Others’ Judgments 
  
If I make a mistake, people will think I am a bad mother. 0.85 0.42 
People will probably think less of me if I make parenting 
mistakes. 
0.85 0.42 
If my baby is crying, people will think I cannot care for 
him/her properly. 
0.83 0.32 
Seeking help with my baby from other people makes me feel 
incompetent. 
0.68 0.37 
Beliefs Related to Maternal Responsibility 
  
If I love my baby, I should want to be with him/her all the 
time. 
0.85 0.51 
I should feel more devoted to my baby. 0.76 0.33 
I am the only person who can keep my baby safe. 0.68 0.47 
Good mothers always put their baby’s needs first. 0.66 0.46 
Beliefs Related to Maternal Role Idealization 
  
It is wrong to feel disappointed by motherhood. 0.88 0.61 
It is wrong to have mixed feelings about my baby. 0.84 0.65 
Negative feelings towards my baby are wrong. 0.75 0.45 
If I fail at motherhood, then I am a failure as a person. 0.69 0.51 
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Table 3 
Summary Statistics and Intercorrelations Among Maternal Attitudes and General Cognitive Biases in Study 1 
 
n Range M(SD) 
AToM 
Total 
AToM 
Factor 1 
AToM 
Factor 2 
AToM 
Factor 3 MAQ DAS 
AToM Total 136 16-58 37.22 
(8.32) 
(.81) .62*** .74*** .83*** .31** .43** 
Others’ Judgments  (AToM Factor 1) 136 4-21 11.34 
(3.84) 
.76*** (.82) .10 .24** .30** .53*** 
Maternal Responsibility (AToM Factor 2) 136 5-24 14.24 
(3.61) 
.96*** .13 (.74) .55*** .16 .13 
Role Idealization (AToM Factor 3) 136 4-23 11.65 
(3.97) 
1.03*** .30** .71*** (.80) .21* .27** 
Maternal Attitudes (MAQ) 111 0-15 4.34 
(2.77) 
.43** .42** .23 .30* (.63) .27** 
Cognitive Biases (DAS) 104 64-178 119.23 
(24.21) 
.50** .62*** .16 .32** .36** (.90) 
* p < 0.05  ** p< 0.01 *** p < 0.001 
Note. Uncorrected correlations are displayed above the diagonal. Correlations below the diagonal have been corrected for attenuation. Internal reliability coefficients are displayed in parentheses on the 
diagonal.
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Table 4 
Descriptive Statistics and Correlations Among Primary Study Measures in Study 2 
 
n Range M(SD) 
AToM 
Total 
AToM 
Factor 1 
Atom 
Factor 2 
Atom 
Factor 3 DAS EPDS STAI DYAD MDPSS 
Maternal Attitudes 
(AToM Total)  
288 12-67 38.8 
(10.6) 
(.86) .73*** .82*** .87*** .50*** .41*** .41*** -.15*** .20** 
Others’ Judgments  
(AToM Factor 1) 
293 4-22 11.5 
(3.9) 
.88*** (.80) .37*** .45*** .57*** .41*** .48*** -.18* .19** 
Maternal Responsibility  
(AToM Factor 2) 
290 4-24 13.8 
(4.3) 
1.03*** .48*** (.73) .62*** .31*** .33*** .30*** -.11 .19** 
Role Idealization  
(AToM Factor 3) 
292 4-24 13.5 
(4.8) 
1.04*** .56*** .81*** (.81) .37*** .25*** .26*** -.09 .12 
Cognitive Biases  
(DAS) 
237 17-94 49.2 
(16.6) 
.57*** .67*** .38*** .43*** (.91) .49*** .58*** -.33*** .16* 
Depressive Symptoms  
(EPDS) 
278 0-25 8.3  
(4.8) 
.47*** .49*** .41*** .30*** .55*** (.87) .79*** -.36*** .30*** 
Anxiety Symptoms 
(STAI) 
240 40-155 73.3 
(21.3) 
.45*** .55*** .36*** .29*** .62*** .86*** (.96) -.43*** .44*** 
Marital Satisfaction 
(DYAD) 
211 73-145 118.8 
(14.5) 
-.17*** -.21* -.13 -.10 -.36*** -.40*** -.46*** (.93) -.21** 
Inadequate Social Support 
(MDPSS) 
229 12-84 70.5 
(13.9) 
.22*** .22** .23** 
 
.17* .17* .33*** .42*** -.22** (.95) 
* p < 0.05  ** p< 0.01 *** p < 0.001 
1 Descriptive statistics are presented for the non-transformed MDPSS. As subjects’ scores on the MDPSS were not normally distributed, correlations were calculated using the transformed variable.  
Note. Uncorrected correlations are displayed above the diagonal. Correlations below the diagonal have been corrected for attenuation. Internal reliability coefficients are displayed in parentheses on the 
diagonal. 
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Table 5 
Multiple Regressions Assessing the Convergent and Predictive Validity of Maternal Attitudes (AToM) in Study 2 
 Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 
 
General 
Cognitive Biases 
(DAS) 
Depressive 
Symptoms 
(EPDS) 
Anxiety 
Symptoms 
(STAI) 
General 
Cognitive Biases 
(DAS) 
Depressive 
Symptoms 
(EPDS) 
Anxiety 
Symptoms 
(STAI) 
 β β β β β β 
Age 
 
0.12 0.04 0.04 0.10 0.02 0.04 
Pregnant vs. Postpartum 
 
0.11 -0.13 -.06 0.11 -0.10 -0.05 
Married vs. Nonmarried 
 
-0.01 -0.01 0.10 0.04 0.03 0.15* 
White vs. Nonwhite 
 
0.07 0.05 0.08 0.04 0.02 0.05 
Maternal Attitudes  
(AToM Total) 
0.50*** 0.43*** 0.43***    
Others’ Judgments  
(AToM1) 
   0.50*** 0.42*** 0.45*** 
Maternal Responsibility  
(AToM2) 
   0.11 0.25** 0.15 
Role Idealization  
(AToM3) 
   0.02 -0.11 -0.04 
R
2
 0.27*** 0.20*** 0.21*** 0.35*** 0.27*** 0.28*** 
* p < 0.05  ** p< 0.01 *** p < 0.001 
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Table 6 
Hierarchical Multiple Regressions Assessing the Incremental Predictive Validity of Maternal Attitudes (AToM Total) in Study 2 
Outcome 
Depressive Symptoms 
(EPDS) 
 Anxiety Symptoms  
(STAI) 
 Model 1
a
 Model 2
b
 Model 3
c
  Model 4
a
 Model 5
b
 Model 6
c
 
 β β β  β β β 
Step 1
a/b/c
        
Age -0.05 0.06 0.06  -0.07 0.01 0.01 
Pregnant vs. Postpartum -0.07 -0.11 -0.11  -0.02 -0.02 -0.02 
Married vs. Nonmarried 0.02 0.03 0.03  0.13 0.14 0.14 
White vs. Nonwhite 0.09 -0.03 -0.03  0.11 0.01 0.01 
Step 2
b
/4
c
        
Lack of Social Support (MDPSS)  0.26** 0.23***   0.33*** 0.27*** 
Marital Satisfaction (DYAD)  -0.29*** -0.17*   -0.28*** -0.19** 
Step 2
a
/3
b/c
        
Cognitive Biases (DAS) 0.50*** 0.42*** 0.40***  0.58*** 0.47*** 0.47*** 
Step 2
c
/3
a
/4
b
        
Maternal Attitudes (AToM) 0.24** 0.15* 0.36***  0.18** 0.18* 0.41*** 
Step 1 R
2
 0.02 0.02 0.02  0.04 0.02 0.02 
Step 2 ΔR2 0.24*** 0.16*** 0.13***  0.32*** 0.22*** 0.16*** 
Step 3 ΔR2 0.04** 0.15*** 0.12***  0.02* 0.20*** 0.16*** 
Step 4 ΔR2  0.02* 0.08***   0.02* 0.12*** 
* p < 0.05  ** p< 0.01 *** p < 0.001 
a In models 1 and 4, demographic variables were entered in step 1, cognitive biases (DAS) were added in step 2, and maternal attitudes (AToM) were added in step 3.  
b In models 2 and 5, demographic variables were entered in step 1, interpersonal risk factors (MDPSS and DYAD) were added in step 2, cognitive biases (DAS) were added in step 3, and maternal 
attitudes (AToM) were added in step 4.  
c In models 3 and 6, demographic variables were entered in step 1, maternal attitudes (AToM) were entered in step 2, cognitive biases (DAS) were added in step 3, and interpersonal risk factors (MDPSS 
and DYAD) were entered in step 4.  
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Table 7 
Hierarchical Multiple Regressions Assessing the Incremental Predictive Validity of Maternal Attitudes (AToM) in Study 2  
 
Depressive Symptoms 
(EPDS) 
 Anxiety Symptoms  
(STAI) 
 Model 1
a
 Model 2
b
 Model 3
c
  Model 4
a
 Model 5
b
 Model 6
c
 
 β β β  β β β 
Step 1
a/b/c
        
Age -0.05 0.06 0.06  -0.07 0.01 0.01 
Pregnant vs. Postpartum -0.07 -0.11 -0.11  -0.02 -0.02 -0.02 
Married vs. Nonmarried 0.02 0.03 0.03  0.13 0.14 0.14 
White vs. Nonwhite 0.09 -0.03 -0.03  0.11 0.00 0.00 
Step 2
b
/4
c
        
Lack of Social Support (MDPSS)  0.26** 0.16*   0.33*** 0.25*** 
Marital Satisfaction (DYAD)  -0.29*** -0.16*   -0.28*** -0.19** 
Step 2
a
/3
b/c
        
Cognitive Biases (DAS) 0.50*** 0.42*** 0.32***  0.58*** 0.47*** 0.38*** 
Step 2
c
/3
a
/4
b
        
Others’ Judgments (AToM1) 0.26*** 0.26** 0.45***  0.22** 0.26** 0.49*** 
Maternal Responsibility (AToM2) 0.20* 0.20* 0.31**  0.13 0.12 0.22* 
Role Idealization (AToM3) -0.12 -0.20* -0.27**  -0.08 -0.09 -0.17 
Step 1 R
2
 0.04 0.02 0.02  0.04 0.02 0.02 
Step 2 ΔR2 0.24*** 0.16*** 0.25***  0.32*** 0.22*** 0.28*** 
Step 3 ΔR2 0.07*** 0.15*** 0.07***  0.04** 0.20*** 0.09*** 
Step 4 ΔR2  0.06** 0.025**   0.05** 0.10*** 
* p < 0.05  ** p< 0.01 *** p < 0.001 
a In models 1 and 4, demographic variables were entered in step 1, cognitive biases (DAS) were added in step 2, and maternal attitudes (AToM) were added in step 3.  
b In models 2 and 5, demographic variables were entered in step 1, interpersonal risk factors (MDPSS and DYAD) were added in step 2, cognitive biases (DAS) were added in step 3, and maternal 
attitudes (AToM) were added in step 4.  
c In models 3 and 6, demographic variables were entered in step 1, maternal attitudes (AToM) were entered in step 2, cognitive biases (DAS) were added in step 3, and interpersonal risk factors (MDPSS 
and DYAD) were entered in step 4.  
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Table 8 
Multiple Regressions Predicting Maternal Attitudes (AToM Total and Subscales) from 
Psychological Symptoms (BSI Subscales) in Study 2 
 
Maternal 
Attitudes 
(AToM 
Total) 
Others’ 
Judgments 
(AToM 
Factor 1) 
Maternal 
Responsibility 
(AToM Factor 
2) 
Role 
Idealization 
(AToM 
Factor 3) 
 β β β β 
Age -0.13 -0.03 -0.16* -0.13 
Pregnant vs. Postpartum 0.05 0.04 -0.06 0.11 
Married vs. Nonmarried 0.05 -0.10 0.09 0.11 
White vs. Nonwhite 0.04 0.06 0.07 -0.01 
Somatization -0.03 0.01 0.01 -0.08 
Obsessiveness 0.26** 0.20* 0.22** 0.21* 
Interpersonal Sensitivity -0.07 -0.07 -0.05 -0.04 
Depression 0.07 0.14 0.05 0.01 
Anxiety -0.03 0.00 -0.07 -0.01 
Hostility 0.22** 0.26** 0.20* 0.09 
Phobic Anxiety 0.15 0.08 0.14 0.14 
Paranoia -0.13 -0.04 -0.21** -0.11 
Psychoticism 0.09 0.02 0.06 0.14 
R
2
 0.26*** 0.21*** 0.22*** 0.18*** 
* p < 0.05  ** p< 0.01 *** p < 0.001 
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Table 9 
Multiple Regressions Predicting Maternal Attitudes (AToM Total and Subscales) from 
Personality Factors (BFI Subscales) in Study 2 
 
Maternal 
Attitudes 
(AToM 
Total) 
Others’ 
Judgments 
(AToM 
Factor 1) 
Maternal 
Responsibility 
(AToM Factor 
2) 
Role 
Idealization 
(AToM 
Factor 3) 
 β β β β 
Age -0.20** -0.10 -0.21** -0.17* 
Pregnant vs. Postpartum 0.05 -0.04 -0.03 0.10 
Married vs. Nonmarried 0.06 -0.04 0.09 0.10 
White vs. Nonwhite 0.05 0.07 0.09 -0.02 
Openness -0.10 -0.01 -0.14 -0.11 
Conscientiousness 0.02 0.01 -0.02 0.07 
Extraversion -0.05 -0.07 -0.04 -0.03 
Agreeableness -0.11 -0.17* -0.04 -0.07 
Neuroticism 0.20* 0.26** 0.13 0.12 
R
2
 0.14** 0.16*** 0.13** 0.09
†
 
† p < 0.10 * p < 0.05  ** p< 0.01 *** p < 0.001 
 
 
 
 
 
 
 
 
 
63 
 
 
 
 
 
 
Chapter 2: 
A Meta-Analysis of Treatments for Perinatal Depression 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter originally appeared as: 
Sockol, L.E., Epperson, C. N., & Barber, J. P. (2011). A meta-analysis of treatments for 
perinatal depression. Clinical Psychology Review, 31, 839-849.  
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Abstract 
This meta-analysis assessed the efficacy of pharmacologic and psychological 
interventions for the treatment of perinatal depression. A systematic review identified 27 
studies, including open trials (n = 9), quasi-randomized trials (n = 2), and randomized 
controlled trials (n = 16) assessing change from pretreatment to posttreatment or 
comparing these interventions to a control group. Uncontrolled and controlled effect sizes 
were assessed in separate meta-analyses. There was significant improvement in 
depressive symptoms from pretreatment to posttreatment, with an uncontrolled overall 
effect size (Hedges’ g) of 1.61 after removal of outliers and correction for publication 
bias. Symptom levels at posttreatment were below cutoff levels indicative of clinically 
significant symptoms. At posttreatment, intervention groups demonstrated significantly 
greater reductions in depressive symptoms compared to control groups, with an overall 
controlled effect size (Hedges’ g) of 0.65 after removal of outliers. Individual 
psychotherapy was superior to group psychotherapy with regard to changes in symptoms 
from pretreatment to posttreatment. Interventions including an interpersonal therapy 
component were found to have greater effect sizes, compared to control conditions, than 
interventions including a cognitive-behavioral component. The implications of the 
findings for clinical practice and future research are discussed.  
 
 
 
 
 
65 
 
 
A Meta-Analysis of Treatments for Perinatal Depression 
Perinatal depression is one of the most common complications of childbearing. 
Approximately 10 to 15% of women experience a clinically significant major depressive 
episode during pregnancy or the early postpartum period (Bennett, Einarson, Taddio, 
Koren, & Einarson, 2004b; Epperson, 1999; Gavin, Gayner, Lohr, Meltzer-Brody, 
Gartlehner, & Swinson, 2005; O’Hara & Swain, 1996). These prevalence estimates 
predominantly reflect rates of depressive symptoms in developed countries; there is 
evidence that rates of depression vary more widely in non-developed countries 
(Halbreich & Karkun, 2006). In addition to the distress and impairment experienced by 
depressed women, depression during this time period is associated with further adverse 
outcomes for both mother and child. Women who experience perinatal depressive 
episodes are at increased risk for subsequent episodes of both postpartum and non-
postpartum depression (Cooper & Murray, 1995). Prenatal depression is associated with 
increased risk for negative birth outcomes, including preterm labor, low birthweight, and 
intrauterine growth restriction (Grote, Bridge, Gavin, Melville, Iyengar, & Katon, 2010). 
Maternal depression during the postpartum period is also a risk factor for a range of 
adverse child outcomes, including behavioral problems and impaired cognitive 
development (Grace, Evindar, & Stewart, 2003).  
Given the prevalence of perinatal depression and the adverse effects this disorder 
has on women and their children, the identification of effective treatments for this 
disorder has important public health implications. Although there is a great deal of 
evidence for the efficacy of both antidepressant medication and psychological 
interventions for depression (see Joffe, Sokolov & Streiner, 1996 and Cuijpers, van 
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Straten, Andersson, & van Oppen, 2008 for meta-analyses of the efficacy of 
antidepressant medication and psychotherapy for depression, respectively), concerns 
unique to the perinatal period may influence the efficacy of these treatments for this 
population (Kim, O’Reardon, & Epperson, 2010). For example, in an attempt to limit 
fetal exposure, antidepressants may be prescribed below therapeutic dosage levels 
(Bennett, Einarson, Taddio, Koren, & Einarson, 2004a). This problem is complicated 
further by the fact that most women actually require higher doses of antidepressant 
medication during pregnancy (Dawes & Chowienczyk, 2001; Hostetter, Stowe, & 
Strader, 2000; Wisner, Perel, & Wheeler, 1993). Concerns regarding the effects of infant 
exposure to antidepressant medication via breastmilk may also lead clinicians to 
prescribe inadequate doses of these medications during the postpartum period (Epperson, 
Anderson, & McDougle, 1997; Epperson, Jatlow, Czarkowski, & Anderson, 2003). 
Biological and psychosocial changes that occur in the context of pregnancy and 
parenting, including sleep deprivation, disruptions to the hormonal milieu, alterations to 
HPA axis functioning, and changes to interpersonal relationships, introduce challenges 
that may affect the efficacy of both pharmacological and psychotherapeutic interventions 
(Dennis & Ross, 2005; Kammerer, Taylor, & Glover, 2006). The efficacy of 
psychological interventions for depression may also be reduced among women who have 
had previous pregnancy losses, complications, or traumatic deliveries, as they may 
experience post-traumatic stress disorder or other comorbid anxiety disorders (Forray, 
Mayes, Magriples, & Epperson, 2009). There are also differences in the acceptability of 
interventions, particularly among women who are pregnant or breastfeeding: the majority 
of women indicate a preference for psychological interventions to antidepressant 
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medication during both pregnancy and the postpartum period, and the overall 
acceptability of antidepressant medication among these groups is low (Chabrol, 
Teissedre, Armitage, Danel & Walburg, 2004; Kim et al., 2011). Thus the identification 
of efficacious interventions, particularly psychological interventions, for this population 
is an important and growing area of research.  
 Two meta-analytic reviews of psychological treatments for postpartum depression 
have found these interventions to be superior to routine care or control conditions. A 
Cochrane review of psychological and psychosocial interventions for postpartum 
depression found that, compared to routine care, these interventions were associated with 
a 30% reduction in relative risk for depressive symptomatology (Dennis & Hodnett, 
2007). Cuijpers, Brännmark, and van Straten (2008) conducted a meta-analysis of 17 
studies in which a psychological intervention initiated during the postpartum period was 
compared to a control or active treatment condition. They reported that psychological 
interventions were superior to control conditions, with an overall effect size in the 
moderate range.  
 In the only published meta-analysis to include interventions for both antenatal and 
postpartum depression, Bledsoe and Grote (2006) evaluated the efficacy of 16 
psychological and pharmacological interventions and found that depressive symptoms 
decreased significantly from pre- to posttreatment. They did not assess the effect of 
treatments compared to control conditions. While their findings provide preliminary 
evidence for the efficacy of these interventions, a major limitation of their meta-analysis 
is the difficulty of interpreting effect sizes representing changes in symptoms from 
pretreatment to posttreatment. As there is evidence that, for many women, depressive 
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symptoms remit naturally over the course of the postpartum period, it is not possible to 
determine whether these effect sizes reflect the effects of the interventions or simply 
natural decreases in symptom levels over time (Heron, O’Connor, Evans, Golding, & 
Glover, 2004). The authors also did not report analyses of homogeneity, tests for outliers 
or publication bias, did not specify whether the analysis was conducted using fixed or 
random effects models, and included multiple effect sizes for three studies in which more 
than one active intervention was assessed. As these methodological issues may 
substantially impact estimation of effect sizes, these results should be interpreted with 
caution.  
 The present meta-analysis addresses several of the limitations of the above 
studies. Unlike Cuijpers, Brännmark, and van Straten (2008), we included 
pharmacological interventions in addition to psychological interventions, and included 
interventions initiated during pregnancy. As many studies of interventions for this 
population are either open trials or do not include a no-treatment control condition, we 
elected not to restrict these analyses to studies in which interventions were compared to a 
control condition. However, to address the possibility that effect sizes calculated from 
these studies may reflect natural symptom remission over time, we also compared active 
treatments to control conditions in studies where it was possible to do so. We have also 
included several new studies of treatments for perinatal depression that have been 
published since these earlier meta-analyses were conducted. The goal of the current meta-
analysis was to assess the efficacy of psychological and pharmacological interventions 
for perinatal depression, defined as the period encompassing pregnancy and the first 12 
months postpartum. Both the overall effect of these interventions on depressive 
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symptoms over time and the relative efficacy of interventions compared to control 
conditions were assessed. We also conducted exploratory moderator analyses assessing 
elements of both study design and interventions as potential moderators of the magnitude 
of effect size when significant heterogeneity of effect sizes was observed.  
Method 
Search Procedures and Selection of Studies 
 Relevant studies were identified through searches of databases through September 
2010, including PubMed and PsycInfo, using the following terms as descriptors: 
postpartum depression, pregnancy AND depression, therapy, drug therapy, cognitive 
behavior therapy, interpersonal psychotherapy, psychodynamic therapy, treatment, and 
treatment outcome. The reference lists of existing meta-analyses, reviews, chapters, and 
retrieved articles were inspected for further studies. Clinical trial databases (including the 
Cochrane Pregnancy and Childbirth Group, Cochrane Depression, Anxiety and Neurosis 
Group, and the International Standard Randomised Controlled Trial Number Register) 
were also reviewed for eligible studies.  
To be included in the meta-analysis, studies had to meet the following inclusion 
criteria: 
(a) Used a prospective pretreatment-posttreatment, quasi-randomized trial or randomized 
controlled trial design.  
(b) Assessed the impact of antidepressant treatment or specified/manualized 
psychological intervention for perinatal depression. Hormonal pharmacological 
interventions, such as estrogen therapy, were excluded. Nonspecific psychosocial 
interventions, such as peer support groups, were excluded. Interventions that did not 
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explicitly target depressive symptoms, such as smoking cessation programs, were also 
excluded.  
(c) Subjects were limited to women with unipolar depression (defined by diagnostic 
criteria or symptom severity) during pregnancy or the postpartum period (defined as 
the 12 months following the birth of a child). 
(d) Reported outcomes for depressive symptoms using a validated self-report or clinician-
administered measure. 
(e) Reported sufficient outcomes to allow for the calculation of either uncontrolled or 
controlled effect sizes. 
A flow chart depicting the search process and exclusion of studies is presented in 
Figure 1. After removal of duplicates, the search procedure yielded 1447 studies. The 152 
studies whose abstracts indicated evaluation of an intervention for antenatal or postnatal 
depression were obtained and reviewed for inclusion. Of these 152 studies, 122 were 
excluded for the following reasons: described an intervention without reporting results of 
an evaluation (n = 10), study design was not a prospective pretest-posttest, quasi-
randomized or randomized controlled trial (e.g., retrospective chart reviews, n = 14), 
prevention studies that included women without elevated depressive symptoms or a 
diagnosis of depression (n = 30), no pharmacological or psychological intervention (e.g., 
exercise, hormonal, and social support interventions, n = 47), population was not 
restricted to women during the perinatal period or with unipolar depression (n = 7), 
studies that reported only qualitative data (n = 3) or insufficient data for the calculation of 
effect sizes (n = 8), and secondary sources for included studies that did not report 
outcomes relevant to the analyses (n = 3). The remaining 30 articles, representing 27 
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studies, were eligible for inclusion in the meta-analysis. When a secondary source was 
available for a given study, the primary source was used to calculate the effect size unless 
reported data was insufficient. Sufficient outcome measures for calculation of effect sizes 
representing change from pretreatment to posttreatment were reported in 25 studies, and 
14 studies reported sufficient outcome measures for calculation of effect sizes 
representing the difference between treatment and control conditions at posttreatment.  
Coding of Studies 
 All studies were coded for: intervention type (antidepressant medication vs. 
psychotherapy vs. combined), study design (open trial vs. quasi-randomized trial vs. 
randomized controlled trial), type of control group (treatment as usual vs. enhanced 
treatment as usual vs. waiting list vs. active), population (antepartum vs. postpartum), 
outcome measure, whether the study required a clinician-verified diagnosis of depression 
for inclusion, treatment length (weeks), and percent attrition. Studies including a 
psychological intervention were also coded for therapeutic orientation, whether therapy 
was conducted individually or in a group format, and the location in which therapy was 
administered (clinic vs. home vs. school). As a majority of studies included the 
Edinburgh Postnatal Depression Scale (EPDS) as an outcome measure, this measure was 
used to calculate effect sizes for all studies reporting EPDS outcomes. For studies that did 
not include the EPDS as an outcome measure, or for which effect sizes could not be 
calculated using the reported EPDS values, the primary outcome measure was used.  
 Effect sizes and moderators were coded by the first author. Three of the variables 
included in the moderator analyses were also coded by a second rater, who was trained in 
the coding scheme and utilized a written coding manual. Observed agreement was 27/27 
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for each variable, or 100%. As all of the variables that were coded for use in the 
moderator analyses were objective variables that were explicitly specified in the studies 
and required minimal judgment on the part of the coder, this reliability check was 
considered adequate.  
Analyses 
 Two separate analyses were conducted. The first analysis assessed the change in 
depressive symptoms from pretreatment to posttreatment using the standardized mean 
gain score for all treatment groups. To differentiate these analyses from those comparing 
treatment to control conditions, these within group effect sizes will be referred to as 
“uncontrolled effect sizes” (Feske & Chambless, 1995). To ensure the independence of 
included effect sizes, a single effect size was calculated on the basis of the overall mean 
and standard deviation of the total group of treated subjects in studies that included more 
than one active treatment. Uncontrolled effect sizes were calculated by dividing the mean 
change from pretreatment to posttreatment by the pooled standard deviation of the 
difference score, corrected for upward bias using Hedges’ g (Hedges, 1981): 
    [
          
      √      ))⁄
] 
where the pooled standard deviation is defined as 
       √     
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Uncontrolled effect sizes were calculated so that positive effect sizes represented a 
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decrease in depressive symptoms from pretreatment to posttreatment.  
None of the studies included in the meta-analysis reported the pretest-posttest 
correlation for the sample or data that would allow this value to be calculated. Following 
the recommendations of Lipsey and Wilson (2001), the test-retest reliability of the 
measures was used as a proxy for the pretest-posttest correlation. These values were 
estimated from published validation studies of each measure; when multiple test-retest 
reliabilities were available for a single measure, r was computed as the weighted mean of 
the reliabilities. As it is likely that these values are inflated estimates of the pretest-
posttest correlation, the overall analyses were also conducted using values of 0.3, 0.5, and 
0.8 as estimates of low, medium, and high correlations, respectively. There were no 
substantive differences between these effect sizes, suggesting that using the test-retest 
correlations as a proxy for this value would not impact the results of the analyses.  
 The second analysis compared the efficacy of active treatments to control 
conditions using the standardized mean group difference. To differentiate these effect 
sizes from those defined previously, these between group effect sizes will be referred to 
as “controlled effect sizes” (Feske & Chambless, 1995). Means and standard deviations 
for the total group of treated subjects were calculated for all studies in which multiple 
active treatments were compared to a control group in order to ensure the independence 
of effect sizes. Controlled effect sizes were calculated by dividing the difference between 
treatment and control means by the pooled standard deviation, corrected for upward bias 
using Hedges’ g (Hedges, 1981):  
    [
     
   
] 
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where the pooled standard deviation is defined as 
     √
     )   
       )   
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and cm is defined as described above. Controlled effect sizes were calculated so that 
positive effects represented lower scores in the intervention group compared to the 
control group.  
The heterogeneity of effect sizes was examined using the Q statistic and the I
2
 
index. Significant Q statistics indicate that the observed range of effect sizes is 
significantly larger than would be expected based on within-study variance. While a 
significant Q statistic indicates heterogeneous effect sizes, nonsignificant Q statistics 
should be interpreted with caution, as heterogeneous effect sizes may yield a 
nonsignificant Q value due to low power. The I
2
 value indicates the proportion of 
variance in effect sizes accounted for by between-study variance. The index has a range 
from 0 to 100; Higgins and colleagues (2003) suggest that 25, 50 and 75% I
2
 values 
indicate low, medium and high levels of hetereogeneity, respectively.  
When analyses indicated significant heterogeneity among effect sizes, exploratory 
analyses were conducted to assess for moderators of effect size. Categorical moderators 
were assessed using an analysis of variance (ANOVA) of mixed-effects models for each 
variable hypothesized to influence the effect size. Meta-regression analyses were 
conducted to assess the effects of continuous moderators. Two types of moderators were 
included in the analyses. The first were variables that reflected elements of the research 
design of included studies; significant findings of moderation would indicate that 
differences in effect sizes could be attributed to methodological variability among studies 
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(e.g., whether studies required a clinician-verified diagnosis for inclusion). The second 
were variables related to characteristics of interventions; for example, pharmacotherapy 
versus psychotherapy and differences between psychological interventions of different 
therapeutic orientations. For studies assessing psychotherapeutic interventions, we also 
assessed whether characteristics of the intervention (including the mode of 
administration, location the intervention was delivered, and therapeutic orientation) were 
related to effect size.  
 Calculations of weighted mean effect sizes, heterogeneity, and moderators were 
conducted using Comprehensive Meta-Analysis, version 2.2.046 (Borenstein, Hedges, 
Higgins, & Rothstein, 2005). A decision was made to estimate overall effect sizes using 
random effects models, as it was presumed that the included studies represent a 
distribution of true intervention effects. Fixed effect models assume that variability in 
effect sizes is due to random error within studies, and that there is a common true effect 
size across all studies. The overall effect size represents the estimate of the true effect 
size for the population of studies, but is not generalizable beyond the sample of included 
studies. In contrast, random effects models assume that variability in effect sizes is due to 
both random error within studies and systematic variability between studies – the true 
effect size is allowed to vary across studies. The overall effect size represents the 
estimated average of the true effect sizes, and results can be generalized to studies not 
included in the analysis. Considerable heterogeneity of effect sizes was expected given 
the differences in study design, interventions, and samples across the included studies. As 
the Q statistic is underpowered in cases of small sample size, random effects models were 
estimated regardless of the observed heterogeneity.  
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 For each of these analyses, the presence of outliers was assessed using the 
sample-adjusted meta-analytic deviance (SAMD) statistic (Huffcutt & Arthur, 1995). A 
more conservative cutoff score of 2.58 was used to consider studies for exclusion from 
the analyses, as extreme values can result from either true population variability or error, 
and removing outliers whose effects represent true variability limits the ability to assess 
the role of moderators (Beal, Corey & Dunlap, 2002). The SAMDs were rank-ordered 
and the scree plots examined to confirm the outlier status of studies with SAMDs above 
this cutoff. In cases where the SAMD value was greater than 2.58 but the scree plot 
suggested that the SAMD was not discrepant from the overall distribution, the study was 
retained to maximize the variance available to assess the role of moderators.  
 Publication bias was assessed by visual examination of funnel plots, Duval and 
Tweedie’s (2000) trim-and-fill procedure, and classic fail-safe N values (Rosenthal, 
1979). First, the effect size for each study was plotted against the study standard error. An 
asymmetric distribution suggests missing studies due to publication bias. When 
asymmetry is present, Duval and Tweedie’s (2000) trim-and-fill procedure provides an 
effect size estimate that corrects for the number and assumed location of the missing 
studies. When this test indicated significant asymmetry in the funnel plot, the overall 
estimates for the model were calculated using the trim-and-fill correction. The fail-safe 
value determines the number of studies with null findings that would be necessary to 
produce a nonsignificant overall effect size. Using Rosenthal’s (1991) recommendation, a 
value of 5K + 10, where K is the number of observed studies, was used as the cutoff for 
an unlikely number of studies.   
Results 
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Study Characteristics 
Table 1 displays characteristics of the 27 studies included in the analyses. Of the 
included studies, 9 were open trials (33%), 2 were quasi-randomized trials (7%), and 16 
were randomized controlled trials (59%). Nineteen studies assessed psychological 
interventions (70%), four assessed pharmacological interventions (15%), and four 
assessed interventions including psychological and pharmacological components (15%). 
Most studies targeted postpartum depression (n = 22, 81%), four targeted antenatal 
depression (15%), and one study included subjects across the perinatal period. Length of 
treatment ranged from 6 to 16 weeks, with an average of 10 weeks. Interpersonal 
psychotherapy (IPT) was the most common psychological intervention (n = 11, 41%), 
followed by cognitive-behavioral (CBT) interventions (n = 9, 33%); other interventions 
included non-directive counseling (n = 3), a Mother-Infant Therapy Group (n = 1), a 
CBT-oriented psychoeducational group (n = 1), manualized supportive psychotherapy (n 
= 2), and psychodynamic therapy (n = 2). Nine studies assessed group interventions 
(33%), 4 included home-based interventions (15%), and one study included a school-
based intervention.  
Table 2 presents characteristics of the included studies indicative of their 
methodological quality. Given the range of designs that were included in the analyses, 
methodological quality was not quantified or used in the weighting of effect sizes. Of the 
27 included studies, 19 included intent-to-treat analyses. As the average attrition rate was 
21%, it is likely that completer analyses represent biased outcomes. In 8 studies, subjects 
were not excluded if they were currently receiving additional treatment for depression, all 
of which were studies of psychological interventions. In some trials, rates of concurrent 
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antidepressant use were quite high (e.g., 54% across both intervention and control groups, 
Klier, Muzik, Rosenblum, & Lenz, 2001). While some studies specifically assessed the 
potential effect of concurrent antidepressant use on outcome (e.g., Honey, Bennett, & 
Morgan, 2002), the inclusion of subjects receiving adjunctive pharmacological treatment 
in trials assessing psychological interventions is a significant limitation of the research 
base for these interventions.  Among the 23 studies that included a psychological 
intervention, most studies provided information regarding therapist characteristics and 
use of therapy manuals. Fifteen studies provided information about therapist training, 13 
indicated that therapists received regular ongoing supervision, and 9 studies assessed for 
adherence to the treatment model. Among the 8 studies that included a pharmacological 
intervention, only 3 included a placebo condition in which both patients and clinicians 
were blind to medication status.  
The included studies vary widely in the demographic characteristics and 
variability of their samples. Most studies were conducted in the United States (n = 13, 
48%), six studies were conducted in Australia (22%), three studies in the United 
Kingdom (11%), and the remaining studies were conducted in Austria (n = 1), Canada (n 
= 1), France (n = 1), and Sweden (n = 2). Fourteen studies (52%) reported at least some 
information regarding the race, ethnicity, or national origin of subjects. In the 10 studies 
(37%) that reported demographic information that provided sufficient data regarding the 
racial composition of their samples, the percentage of subjects who identified as 
racial/ethnic minorities ranged from 0% (Klier et al., 2001) to 100% (Miller et al., 2008), 
with a mean of 45.6% and standard deviation of 32.7%. Twenty-three studies (85%) 
reported information regarding the marital status of subjects. The percentage of single 
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subjects in these studies ranged from 0% (O’Hara et al., 2000, who required women to be 
married of living with a partner for 6 months or more to be eligible to participate) to 
72.7% (Miller et al., 2008). Twenty studies (74%) reported information regarding parity 
or the number of children in subjects’ households. Of the 14 studies that reported the 
percentage of primiparous subjects, this value ranged from 25% (O’Hara et al., 2000) to 
85.1% (Wiklund, Mohlkert, & Edman, 2010), with a mean of 55.8% and standard 
deviation of 17.7%.  
Uncontrolled Effect Sizes 
 Table 3 presents the results of the random effects model for uncontrolled effect 
sizes, representing results from 25 studies. These values should be interpreted with 
caution, as they reflect within-study change and cannot differentiate between reductions 
in symptoms that occurred as a result of the intervention versus the passage of time. All 
studies demonstrated significant positive effects, indicating improvement over 
pretreatment scores, with Hedges’ g ranging from 0.78 to 4.39. Two studies had SAMD 
values greater than 2.58. Visual inspection of the scree plot of the rank-ordered SAMD 
scores suggested that the value for the study by Grote and colleagues (2009) was 
consistent with the overall distribution of SAMD scores, while the study by Appleby and 
colleagues (1997) was discrepant. This study was excluded from subsequent analyses; the 
average effect size excluding this outlier was 1.54 (95% CI 1.34-1.73, p < 0.001). 
The Q statistic indicated that there was significant heterogeneity among the effect 
sizes (p < 0.001). The I
2
 value indicated a high level of heterogeneity, with 86% of the 
variance in effect sizes attributable to between-study variance. The fail-safe value was 
9102, far exceeding the tolerance level for an unlikely number of non-significant studies 
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(130). The funnel plot was slightly asymmetric; trim-and-fill procedures suggested that 
two studies with effect sizes to the right (more strongly positive) of the mean were 
missing. The corrected average effect size was 1.61 (95% CI 1.40-1.81). This adjusted 
value suggests that if the included studies do reflect a publication bias, it is in the 
direction of underestimating the true effect size of the interventions.  
As the magnitude of uncontrolled effect sizes is difficult to interpret, a separate 
meta-analysis was conducted to determine the average level of depressive symptoms at 
posttreatment. A random effects model was used to calculate the overall mean for the 15 
studies that used the EPDS as an outcome measure. The average score at posttreatment 
was 8.62 (95% CI 7.66-9.58), which is below the commonly used cutoff of 11-13 
considered indicative of clinically significant depressive symptoms (Cox, Chapman, 
Murray, & Jones, 1996). A second random effects model was used to calculate the 
overall mean for the 5 studies that used the Hamilton Depression Rating Scale as an 
outcome measure. The average score at posttreatment was 6.12 (95% CI 2.90-9.33), 
which is also below the cutoff of 7 commonly considered indicative of symptom 
remission (Frank et al., 1991).  
Moderator Analyses: Uncontrolled Effect Sizes 
 As both the Q statistic and I
2 
index indicated significant heterogeneity of effect 
sizes, exploratory analyses of potential moderators were conducted. These analyses 
assessed whether effect sizes differed on the basis of characteristics of the included 
studies and interventions. As the reporting of sample characteristics was inconsistent 
across studies, none of these variables were assessed as potential moderators. Subgroups 
including only one study were excluded from moderator analyses.  
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 Study characteristics. Four characteristics of the included studies were assessed 
as potential moderators: study design, type of sample, whether a clinician-verified 
diagnosis of a depressive disorder was required for inclusion in the study, and outcome 
measure (see Table 4). No significant differences in the average effect size were found 
among the three types of study designs, between studies assessing interventions for 
antenatal depression versus postpartum depression, or between studies that did and did 
not require a clinician-verified diagnosis for inclusion. Studies for which the effect size 
was calculated using the BDI had significantly smaller effect sizes (g = 1.10, n = 2) than 
studies for which the effect size was calculated using the EPDS (g = 1.62, n = 16) or 
HDRS (g = 1.65, n = 5).  
 Intervention variables. Two characteristics of the interventions were assessed 
for potential moderation (see Table 4). Studies including three types of interventions 
were compared: pharmacological, psychological, and combined (pharmacological + 
psychological). There were no significant differences in effect sizes among the three 
major types of interventions. Meta-regression analysis was used to assess the relationship 
between length of treatment and effect size. There was a trend for a positive association 
of length of treatment with effect size; however, this result did not reach significance 
(slope = 0.03, p = 0.07). 
For studies that included a psychological intervention, three characteristics of the 
intervention were assessed for moderation: method of administration (individual vs. 
group), location of administration (clinic vs. home), and therapeutic orientation. Studies 
in which therapy was administered individually had significantly larger effect sizes (g = 
1.79, n = 12) than those utilizing a group therapy format (g = 1.23, n = 7). There was a 
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trend (p = 0.08) toward home-administered treatments (g = 2.33, n = 2) having larger 
effect sizes than clinic-based treatments (g = 1.64, n = 16).  
Four analyses were conducted to assess whether inclusion of two well-established 
therapeutic interventions, cognitive-behavioral therapy (CBT) or interpersonal 
psychotherapy (IPT), was a moderator of effect size. First, studies were categorized as 
either including or not including each approach. There was a trend for studies that 
included one of these interventions having larger effect sizes (g = 1.61, n = 18) than 
studies that included other psychological interventions (g = 1.11, n = 2). There were not 
significant differences between studies that included CBT compared to those that did not 
(including IPT interventions) or between studies that included IPT compared to those that 
did not (including CBT interventions). Finally, the effect sizes of studies including CBT 
and IPT were compared to one another. No study included both a CBT and an IPT 
intervention. There was not a significant difference in the average effect size of the two 
interventions.  
Controlled Effect Sizes 
 Table 5 presents the results of the random effects model for controlled effect 
sizes, representing results from 14 studies. All effect sizes were positive, indicating 
superiority of treatment to control conditions, with Hedges’ g ranging from 0.31 to 2.33. 
Two studies had SAMD values greater than 2.58. Visual inspection of the scree plot of 
the rank-ordered SAMD scores indicated that the value for the study by Milgrom and 
colleagues (2005) was consistent with the overall distribution of SAMD scores, while the 
study by Chabrol and colleagues (2002) was discrepant. This study was excluded from 
subsequent analyses. The average effect size, excluding the outlier, was 0.65 (95% CI 
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0.45-0.86, p < 0.001). Cohen’s U3 metric provides an intuitive metric through which to 
interpret the magnitude of this effect size; this value indicates that 74% of subjects in 
treatment conditions could be expected to report levels of depressive symptoms lower 
than the mean of the control group (Lipsey & Wilson, 2001).  
The Q statistic indicated that there was significant heterogeneity among the effect 
sizes (p < 0.05). The I
2 
value indicated a medium level of heterogeneity, with 43% of the 
variance in effect sizes attributable to between-study variance. The fail-safe N was 229, 
which substantially exceeds the tolerance level for an unlikely number of non-significant 
studies (75). The funnel plot was symmetric and the trim-and-fill procedures suggested 
no missing studies.  
Moderator Analyses: Controlled Effect Sizes 
 As both the Q statistic and I
2 
value indicated heterogeneity among effect sizes, 
exploratory analyses of potential moderators were conducted to assess whether effect 
sizes differed on the basis of study or intervention characteristics. Subgroups including 
only one study were excluded from moderator analyses.  
Study characteristics. As for uncontrolled effect sizes, target population, 
diagnostic status, and outcome measure were assessed as potential moderators (see Table 
6). In addition, the average effect size for studies utilizing different control groups 
(treatment as usual vs. enhanced treatment as usual vs. waiting list control) was assessed. 
The only significant moderator of effect size was the target population of the study; 
interventions for antenatal depression had significantly larger effect sizes (g =1.18, n = 2) 
than those for postpartum depression (g = 0.57, n = 11).  
Intervention variables. As only one study assessing pharmacological treatment 
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was included in this analysis, it was not possible to compare the average effect size for 
pharmacological vs. psychological interventions. Length of treatment was assessed for 
moderation using meta-regression analysis; treatment length was not significantly 
associated with effect size (slope = 0.05, p = 0.12).  
For the studies assessing psychological interventions, three potential moderators 
were assessed (see Table 6). There were no significant differences among average effect 
sizes with respect to the method of administration of therapy (individual vs. group vs. 
combined). There was a trend for studies that included clinic-based interventions to have 
larger effect sizes (g = 0.73, n = 9) than studies that included home-based interventions (g 
= 0.38, n = 2). Studies that included an IPT intervention were compared to those that 
included a CBT intervention. As only one study included an intervention representing 
different therapeutic orientation, analyses comparing IPT and CBT separately to all other 
treatments combined were not conducted. Studies that included an IPT intervention had 
significantly larger effect sizes (g = 0.96, n = 5) than those that included a CBT 
intervention (g = 0.40, n = 6). 
Discussion 
 The results of these analyses provide evidence for the efficacy of a range of 
interventions for perinatal depression. All studied interventions demonstrated 
symptomatic improvement from pretreatment to posttreatment, with posttreatment means 
for both the EPDS and HDRS below cutoffs for clinically significant depressive 
symptoms. All interventions also demonstrated superiority to control conditions, with an 
overall effect size in the moderate range. The overall effect size (g = 0.65) is comparable 
to that found in a meta-analysis of the efficacy of psychological treatments for adult 
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depression, which reported an average posttreatment effect size of 0.67 (Cuijpers, Smit, 
Bohlmeijer, Hollon, & Andersson, 2010).   
 Our finding indicating the superiority of IPT to CBT for the treatment of perinatal 
depression has important implications for both clinicians and researchers. This is 
consistent with the findings of Bledsoe and Grote (2006), who reported that IPT 
interventions were associated with greater decreases in symptoms from pretreatment to 
posttreatment; our study is the first to find that IPT results in a greater reduction in 
symptoms compared to control conditions, as well. It is possible that this finding reflects 
a true difference in the efficacy of a specific form of psychotherapy for this population. In 
describing their adaptations of IPT for postpartum depression, Stuart and O’Hara (1995) 
noted that the focus on interpersonal problem areas, particularly role transitions and 
interpersonal disputes, may be particularly well-suited to the problems women experience 
during the perinatal period, such as disruptions in their interpersonal relationships. While 
a possible interpretation of this finding is that IPT is a more efficacious intervention for 
depression among this population, our findings may also have resulted from 
characteristics of the included studies unrelated to the interventions themselves. Studies 
assessing an IPT intervention were more likely to report utilization of a therapy manual; 
the implementation of manualized IPT for this population is likely facilitated by the ready 
availability of a treatment manual containing specific adaptations for postpartum 
depression (O’Hara, Stuart, Gorman, & Wenzel, 2000). It is unclear whether studies of 
CBT interventions did not utilize a specific therapy manual or whether these studies 
simply followed widely accepted and available manuals for CBT for depression (e.g., 
Beck, Rush, Shaw, & Emery, 1987). Studies assessing a CBT intervention were also 
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more likely to include other interventions, either as an explicit element of the intervention 
itself (e.g., Honey, Bennett, & Morgan, 2002¸ whose intervention included educational, 
cognitive-behavioral, and relaxation components), or because a single effect size was 
calculated for studies including multiple active treatments for the purpose of our analyses 
(e.g., Cooper, Murray, Wilson, & Romaniuk, 2003, who included CBT, psychodynamic, 
and nondirective counseling interventions). Given the possibility that other aspects of 
study design may have been confounded with the therapeutic orientation of the 
interventions included in the different studies, our results regarding the superiority of IPT 
to CBT should be interpreted with caution. Further research evaluating the efficacy of 
well-defined cognitive-behavioral interventions for this population, particularly trials in 
which faithfully administered CBT and IPT protocols are compared directly to one 
another, is necessary to establish whether IPT is truly a more effective intervention for 
perinatal depression. Such studies would be greatly beneficial given the low acceptability 
of antidepressant medication in this population and preference for non-pharmacologic 
treatments, including psychotherapy (Kim et al., 2011). 
 Another important moderator identified in these analyses is the superiority of 
individually-administered therapeutic interventions to those conducted in a group format. 
Uncontrolled effect sizes were larger for studies in which therapy was conducted on an 
individual basis; a comparable pattern was observed for controlled effect sizes, although 
this difference did not reach significance due to the smaller number of included studies. 
There has been great interest in the potential use of group treatments for perinatal 
depression, and some have suggested that the format may be particularly well-suited for 
this population because it provides an opportunity for normalizing women’s experiences 
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and decreasing social isolation (Mulcahy, Reay, Wilkinson, & Owen, 2009). The results 
of these analyses suggest that these benefits may not be sufficient to lead to a reduction in 
depressive symptoms comparable to that which can be achieved through individual 
psychotherapy.  
 Our results suggest that further assessment of home-based interventions is 
necessary in order to determine the efficacy of these programs. There was a trend for 
depressive symptoms to decrease more over time in studies that incorporated home-based 
interventions; however, there was also a trend for greater effects in studies that 
incorporated clinic-based interventions with respect to the superiority of treated groups to 
control conditions. Both of these results should be interpreted with caution, as only two 
studies of home-based interventions were included in these moderator analyses. Further 
research, ideally trials in which comparable interventions administered either in a clinic 
or home setting can be directly compared, is necessary to determine whether the location 
in which therapy is conducted effects the efficacy of these interventions.  
 There was a trend for longer treatments to have larger uncontrolled effect sizes, 
but treatment length was not associated with controlled effect sizes. As uncontrolled 
effect sizes do not distinguish between the effects of interventions and decreases in 
symptoms over time, this raises the concern that the apparent effects of treatment may 
simply reflect a natural decrease in symptoms over time. There is evidence that, for most 
women, high levels of depressive symptoms naturally remit over the perinatal period 
(Heron, O’Connor, Evans, Golding, & Glover, 2004). One study included in these 
analyses found that three active treatment groups were only superior to routine primary 
care at 4.5 months postpartum; by 9 months postpartum the depressive symptoms of the 
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control group had declined to levels comparable to those observed in the treated groups, 
and differences among the groups remained nonsignificant through five years postpartum 
(Cooper, Murray, Wilson & Romaniuk, 2003). However, other included studies found 
that treatment groups continued to be superior to control groups at follow-up times 
ranging from 3-6 months posttreatment (Grote et al., 2009; Honey, Bennett & Morgan, 
2002; Mulcahy, Reay, Wilkinson & Owen, 2009).  
 Unfortunately, the number of studies that have included follow-up assessments of 
treated subjects is too small for a meta-analysis of long-term outcomes. Five studies in 
which an intervention was compared to a control group reported follow-up outcomes, 
with the timing of follow-up assessments ranging from 3 months to 5 years posttreatment. 
An initial analysis suggested that the treated group remained superior at the first 
posttreatment follow-up assessment (which ranged from 3 to 6 months posttreatment), 
with a positive effect size in the moderate range. However, the SAMD values indicated 
that two studies were significant outliers, and the fail-safe N for this analysis indicated 
that the number of studies with null results necessary to reduce the effect size to zero was 
below the tolerance limit. Further assessment of long-term outcomes for subjects in 
controlled trials of interventions for perinatal depression are necessary to assess whether 
the benefits of treatment for perinatal depression are maintained over time.  
 The present meta-analysis has several limitations. Reflecting the status of the 
field, the number of included studies is relatively small, particularly for the analysis of 
controlled effect sizes. Moderator analyses were likewise limited by the small number of 
included studies. The quality of studies assessing interventions among this population is 
somewhat limited (see also Cuijpers, Brännmark, & van Straten, 2008; Dennis, 2004). Of 
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particular concern is the fact that 8 studies of psychological interventions did not exclude 
subjects who were receiving pharmacological treatment, and rates of concurrent 
antidepressant use were quite high in some of these studies. As this raises the possibility 
that the purported effects of psychotherapy in these studies could have been the result of 
pharmacological interventions, future research is necessary both to establish the separate 
effects of psychotherapy and pharmacotherapy (by excluding subjects receiving 
concurrent treatment from research) and to explicitly assess the efficacy of combined 
psychological and pharmacological treatments. Compared with psychological 
interventions, there has been relatively little assessment of the efficacy of antidepressant 
medication in this population. Of the seven studies that included antidepressant treatment, 
three were open trials and two compared a combined treatment to either psychological or 
pharmacological monotherapy. Given the ethical concerns regarding the use of no-
treatment control groups in treatment studies with this population, further studies in 
which pharmacological treatments are directly compared to psychological or combined 
interventions are necessary to address the relative efficacy of these interventions. Barber 
(2009) also suggested that there is room for large scale, relatively well controlled, 
naturalistic studies for examining the efficacy of psychotherapy, as the field does not 
have the resources to conduct all the RCTs that need to be conducted.  Finally, because 
psychotherapies are large packages, research that focuses on specific interventions from a 
package could be used to determine which specific interventions are particularly useful 
(e.g., Barber et al., 1996, DeRubeis & Feeley, 1990; Webb, DeRubeis, & Barber, 2010). 
 In summary, these meta-analyses demonstrated that a range of interventions are 
effective in the reduction of perinatal depressive symptoms. Reductions in symptoms 
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from prettest to posttreatment are large, and symptom levels at posttreatment are below 
cutoffs for clinically significant symptoms. These interventions reliably lead to moderate 
reductions in depressive symptoms compared to control groups. Interestingly, there was 
initial evidence that IPT may be more effective than CBT, although further research is 
necessary to establish whether this can be attributed to methodological differences 
between studies assessing the two forms of psychotherapy.  Relatively few studies of 
antidepressant medication for this population have been conducted compared to 
psychological interventions, and overall most interventions have not been assessed in 
comparison to control or other active treatment conditions. Given the prevalence of 
perinatal depression and the negative outcomes associated with depressive symptoms 
during this period, the identification of effective and acceptable treatments for this 
population is vitally necessary. Although more research is needed to confirm and extend 
the results of these meta-analyses, these results suggest a range of interventions for 
further investigation as treatments for this disorder. 
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Table 1 
 
Characteristics of Studies Assessing Interventions for Perinatal Depression 
 
Study Country N 
Study 
Design 
Control 
Type Population Intervention Dx Measure 
Tx 
Length 
% 
Attrition Treatment Format Admin 
Appleby et al.   
(1997) 
UK 87 RCT  POST COMB Y EPDS 12 30 CBT IND CLIN 
Chabrol et al.   
(2002) 
FR 48 RCT TAU POST THER Y EPDS 12 0 CBT IND HOME 
Clark et al.  
(2003) 
US 39 QRT WL POST THER Y BDI 12 10 M-ITG + IPT COMB CLIN 
Cohen et al.  
(2001) 
US 15 OT  POST MED Y HDRS 8 33 Venlafaxine   
Cooper et al.  
(2003) 
UK 193 RCT TAU POST THER Y EPDS 10 17 
CBT + NDC + 
PDT 
IND HOME 
Craig et al. 
(2005) 
AUS 16 OT  POST THER N EPDS 9 13 CBT GRP CLIN 
Freeman et al.  
(2008) 
US 59 RCT  MIXED COMB Y EPDS 8 34 
SUPP + Omega-3  
Fatty Acids 
IND CLIN 
Grote et al.  
(2009) 
US 53 RCT TAU+ ANTE THER Y EPDS NS 13 IPT IND CLIN 
Honey et al.  
(2002) 
UK 45 RCT TAU POST THER N EPDS 8 9 PEG GRP CLIN 
Klier et al.  
(2001) 
AUST 17 OT  POST THER Y EPDS 12 35 IPT GRP CLIN 
Meager & Milgrom  
(1996) 
AUS 20 RCT WL POST THER N EPDS 10 40 CBT GRP CLIN 
Milgrom et al.  
(2005) 
AUS 120 RCT TAU POST THER Y BDI 12 37 CBT + NDC COMB CLIN 
Miller et al. 
(2008) 
US 11 OT  ANTE THER Y EPDS 12 0 IPT GRP SCHOOL 
Misri et al.  
(2004) 
CAN 35 RCT  POST COMB Y EPDS 12 9 CBT IND CLIN 
Mulcahy et al.  
(2009) 
AUS 50 RCT TAU POST THER Y EPDS 8 15 IPT GRP CLIN 
O'Hara et al.  
(2000) 
US 99 RCT WL POST THER Y HDRS 12 18 IPT IND CLIN 
Pearlstein et al.  
(2006) 
US 23 QRT  POST COMB Y EPDS 12 22 IPT IND CLIN 
Prendergast & Austin  
(2001) 
AUS 37 RCT TAU+ POST THER Y EPDS 6 0 CBT IND HOME 
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Study Country N 
Study 
Design 
Control 
Type Population Intervention Dx Measure 
Tx 
Length 
% 
Attrition Treatment Format Admin 
Reay et al.  
(2006) 
AUS 18 OT  POST THER Y EPDS 8 6 IPT GRP CLIN 
Spinelli 
(1997) 
US 13 OT  ANTE THER Y EPDS 16 31 IPT IND CLIN 
Spinelli & Endicott  
(2003) 
US 50 RCT ACT ANTE THER Y EPDS 16 24 IPT IND CLIN 
Stowe et al.  
(1995)  
US 26 OT  POST MED Y BDI 8 19 Sertraline   
Stuart & O'Hara  
(1995) 
US 12 OT  POST THER Y HDRS NS 42 IPT IND CLIN 
Suri, Burt, & Altshuler  
(2005) 
US 4 OT  POST MED Y HDRS 8 25 Nefazodone   
Wickberg & Hwang  
(1996) 
SWE 48 RCT TAU POST THER N MADRS 6 15 NDC IND COMB 
Wiklund, Mohlkert, & Edman 
(2010) 
SWE 66 RCT TAU POST THER N EPDS 7 0 CBT IND CLIN 
Yonkers et al. 
(2008) 
US 70 RCT PLA POST MED Y HDRS 8 56 Paroxetine   
Note. Dx = required clinician-administered diagnostic assessment, Tx Length = treatment length in weeks, Admin = Location of therapy administration, AUS = Australia, AUST = Austria, CAN = 
Canada, FR = France, SWE = Sweden, UK = United Kingdom, US = United States, OT = open trial, QRT = quasi-randomized trial, RCT = randomized controlled trial, TAU = treatment as usual, TAU+ 
= enhanced treatment as usual, WL = waiting list, ACT = active control, PLA = placebo, ANTE = antepartum, POST = postpartum, MIXED = antepartum + postpartum, MED = antidepressant 
medication, COMB = combined antidepressant medication + psychotherapy, THER = psychotherapy, BDI = Beck Depression Inventory, EPDS = Edinburgh Postnatal Depression Scale, HDRS = 
Hamilton Depression Rating Scale, MADRS = Montgomery-Asberg Depression Rating Scale, CBT = cognitive-behavioral therapy, IPT = interpersonal psychotherapy, M-ITG = mother-infant therapy 
group, NDC = nondirective counseling, PEG = psychoeducational group, PDT = psychodynamic therapy, SUPP = manualized supportive psychotherapy, COMB = combined individually + group 
administered, IND = individually-administered, GRP = group-administered, CLIN = clinic-based intervention, COMB = combined clinic- + home-based intervention, HOME = home-based intervention, 
SCHOOL = school-based intervention 
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Table 2 
 
Methodological Quality of Studies Assessing Interventions for Perinatal Depression  
 
 
RCTs Psychological Interventions 
Pharmacologic 
Interventions 
Study ITT 
Char 
Sample 
Concurr 
Tx 
Blind 
Assess Random Spec Ther Manual Trng Super Adher 
Blind 
Clinic Blind Pt 
Open Trials             
Cohen et al.  
(2001) 
+ + NS NS       − − 
Craig, Judd, & Hodgins  
(2005) 
− − NS NS  + + + − −   
Klier et al.  
(2001) 
+ + Y −  + + + − −   
Miller et al. 
 (2008) 
+ + N +  + + − − −   
Reay et al.  
(2006 US) 
+ + Y +  + + + + +   
Spinelli,  
(1997) 
+ + NS NS  − − − − −   
Stowe et al.  
(1995)  
− + NS −       − − 
Stuart & O'Hara  
(1995) 
− + Y NS  − − − − −   
Suri, Burt, & Altshuler 
(2005) 
− − NS +       − − 
Quasi-Randomized Trials             
Clark, Tluczek, & Wenzel 
(2003) 
− + Y NS  + + + + −   
Pearlstein et al.  
(2006) 
− + N NS  + − + + − − − 
Randomized Controlled Trials           
Appleby et al.   
(1997) 
+ + NS + + + − − + + + 
Chabrol et al.   
(2002) 
+ + N − − + + + +   
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RCTs Psychological Interventions 
Pharmacologic 
Interventions 
Study ITT 
Char 
Sample 
Concurr 
Tx 
Blind 
Assess Random Spec Ther Manual Trng Super Adher 
Blind 
Clinic Blind Pt 
Cooper et al.  
(2003) 
+ + NS + − + + + +   
Freeman et al.  
(2008) 
+ + N NS − − + − − + + 
Grote et al.  
(2009) 
+ + N NS + + + + +   
Honey et al.  
(2002) 
+ + Y NA + + − − −   
Meager & Milgrom  
(1996) 
− + Y NA − + − − −   
Milgrom et al.  
(2005) 
+ + N NA − + + + +   
Misri et al.  
(2004) 
+ + N − + + + − − − − 
Mulcahy et al.  
(2009) 
+ + Y + + + + + +   
O'Hara et al.  
(2000) 
+ + NS − + + + + +   
Prendergast & Austin 
(2001) 
+ + Y NS + + + + +   
Spinelli, & Endicott 
(2003) 
+ + N NS + + + + +   
Wickberg & Hwang 
(1996) 
− + N + + + − + +   
Wiklund, Mohlkert, & 
Edman (2010) 
+ + Y NA + + − − −   
Yonkers et al. 
(2008) 
+ + N + +     + + 
Note. ITT = report intent-to-treat analyses, Char Sample = specify characteristics of sample, Concurr. Tx = subjects allowed to receive concurrent antidepressant or psychological treatment, Blind 
Assess. = clinician-administered diagnostic measures conducted by independent evaluator blind to treatment condition, Random. = specification of method of randomization, Spec. Ther. = specify 
therapist characteristics, Manual = specify use of therapy manual, Trng = describe therapist training, Super.  = describe therapist supervision, Adher. = indicate therapy was assessed for adherence to 
model, Blind Clinic. = clinician blind to treatment status, Blind Pt. = patient blind to treatment status, + = yes, − = no, NA = not applicable, NS = not specified, Y = yes, N = no 
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Table 3 
Random Weighted Uncontrolled Effect Sizes from  Studies Assessing Interventions 
for Perinatal Depression  
Study n Hedges’ g SAMD   
Appleby et al.  (1997) 87 4.39*** 10.70
1
   
Chabrol et al.  (2002) 18 1.92*** 0.46   
Clark, Tluczek, & Wenzel (2003) 24 1.03*** -1.30   
Cohen et al. (2001) 15 1.68*** 0.03   
Craig, Judd, & Hodgins (2005) 14 1.44*** -0.33   
Freeman et al. (2008) 51 1.29*** -1.12   
Grote et al. (2009) 25 3.00*** 2.82   
Honey et al. (2002) 23 0.78*** -1.76   
Klier et al. (2001) 17 1.35*** -0.52   
Meager & Milgrom (1996) 6 0.95* -0.59   
Miller et al. (2008) 11 0.91*** -0.98   
Misri et al. (2004) 35 1.72*** 0.17   
Mulcahy et al. (2009) 23 1.56*** -0.20   
O'Hara et al. (2000) 48 2.05*** 1.15   
Pearlstein et al. (2006) 23 2.66*** 2.02   
Prendergast & Austin (2001) 17 2.60*** 1.61   
Reay et al. (2006) 18 1.61*** -0.09   
Spinelli, & Endicott (2003) 21 1.20*** -0.88   
Spinelli, (1997) 13 1.28*** -0.55   
Stowe et al. (1995)  19 1.20*** -0.83   
Stuart & O'Hara (1995) 6 1.39*** -0.23   
Suri, Burt, & Altshuler (2005) 3 1.67*** 0.00   
Wickberg & Hwang (1996) 20 0.83*** -1.53   
Wicklund, Mohlkert, & Edman (2010) 66 2.03*** -0.40   
Yonkers et al. (2008) 17 1.42*** 0.92   
 k Hedges’ g 95% CI Q(df) I2 
Total (all studies) 25 1.66*** 1.41-1.91 280.99(24)*** 91.46 
Total (outlier excluded) 24 1.54*** 1.34-1.73 159.22(23)*** 85.56 
Total (trim-and-fill correction)  1.61 1.40-1.81 199.09  
* p < 0.05, ** p < 0.01, *** p < 0.001 
1 Outlier excluded from subsequent analyses.  
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Table 4 
 
Analyses of Moderation for Uncontrolled Effect Sizes 
 
Moderator n Hedges’ g 95% CI Q(df) p 
Study Design    1.86(2) 0.39 
Open Trial 9 1.39*** 1.22-1.56   
Quasi-Randomized Trial 2 1.81* 0.22-3.41   
RCT 13 1.62*** 1.32-1.92   
Population    0.003(1) 0.96 
Antepartum 4 1.57*** 0.76-2.38   
Postpartum 19 1.55*** 1.33-1.77   
Clinician-Verified Diagnosis    1.82(1) 0.18 
Yes 19 1.61*** 1.40-1.82   
No 5 1.22*** 0.69-1.75   
Measure    15.44(2) 0.000*** 
BDI 2 1.10*** 0.94-1.27   
EPDS 16 1.62*** 1.34-1.89   
HDRS 5 1.65*** 1.35-1.95   
Intervention Type    1.09(2) 0.58 
Combination 3 1.83*** 1.17-2.49   
Medication 4 1.46*** 1.22-1.69   
Therapy 17 1.51*** 1.22-1.79   
Therapy Type    6.93(1) 0.008** 
Group 7 1.23*** 0.95-1.51   
Individual 12 1.79*** 1.48-2.10   
Therapy Location    3.16(1) 0.08 
Clinic 16 1.64*** 1.36-1.92   
Home 2 2.33*** 1.63-3.03   
CBT/IPT vs. Other Psychological    3.72(1) 0.05* 
CBT/IPT 18 1.61*** 1.34-1.89   
Other 2 1.11*** 0.67-1.54   
CBT vs. Other Psychological     0.14(1) 0.71 
CBT 7 1.63*** 1.16-2.10   
Other 13 1.52*** 1.21-1.83   
IPT vs. Other Psychological    0.23(1) 0.64 
IPT 11 1.61*** 1.25-1.97   
Other 9 1.49*** 1.13-1.85   
CBT vs. IPT    0.003(1) 0.95 
CBT 7 1.63*** 1.16-2.10   
IPT 11 1.61*** 1.25-1.97   
* p < 0.05, ** p < 0.01, *** p < 0.001 
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Table 5 
Random Weighted Controlled Effect Sizes from Studies Comparing Interventions 
for Perinatal Depression to Control Conditions  
Study n Hedges’ g SAMD   
Chabrol et al. (2002) 48 2.33*** 5.38
1
   
Clark, Tluczek & Wenzel (2003) 35 0.46 -0.89   
Cooper et al. (2003) 184 0.39* -2.42   
Grote et al. (2009) 53 1.35*** 2.14   
Honey, Bennett & Morgan (2002) 45 0.36 -1.35   
Meager & Milgrom (1996) 12 0.97 0.31   
Milgrom et al. (2005) 192 0.31 -2.95   
Mulcahy et al. (2009) 50 0.63* -0.47   
O'Hara et al. (2000) 99 1.19*** 2.13   
Prendergast & Austin (2001) 37 0.31 -1.35   
Spinelli  & Endicott (2003) 38 0.96** 0.57   
Wickberg & Hwang (1996) 41 0.81* 0.14   
Wiklund, Mohlkert, & Edman (2010) 33 0.51* -0.73   
Yonkers et al. (2008) 31 0.60 -0.44   
 k Hedges’ g 95% CI Q(df) I2 
Total 14 0.76*** 0.50-1.03 40.75(13)*** 68.10 
Total (excluding outlier) 13 0.65*** 0.45-0.86 21.12(12)* 43.19 
* p < 0.05, ** p < 0.01, *** p < 0.001 
1 Outlier excluded from subsequent analyses.  
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Table 6 
 
Analyses of Moderation for Controlled Effect Sizes 
 
Moderator n Hedges’ g 95% CI Q(df) p 
Control Type    3.72(2) 0.16 
TAU 6 0.45*** 0.27-0.63   
TAU+ 2 0.84 -2.04   
Wait List 3 0.93*** 0.45-1.41   
Population    6.24(1) 0.01* 
Antepartum 2 1.18*** 0.74-1.62   
Postpartum 11 0.57*** 0.38-0.75   
Clinician-Verified Diagnosis    0.003(1) 0.96 
Yes 10 0.65*** 0.40-0.90   
No 3 0.66*** 0.30-1.02   
Measure    3.87(2) 0.14 
BDI 2 0.35* 0.02-0.68   
EPDS 8 0.63*** 0.38-0.87   
HDRS 2 0.97*** 0.41-1.53   
Therapy Type    3.41(2) 0.18 
Combined 2 0.35* 0.02-0.68   
Group 3 0.55** 0.17-0.93   
Individual 7 0.78*** 0.46-1.09   
Therapy Location    2.96(1) 0.09 
Clinic 9 0.73*** 0.45-1.00   
Home 2 0.38* 0.09-0.67   
CBT vs. IPT    8.81(1) 0.003** 
CBT 6 0.40*** 0.21-0.59   
IPT 5 0.96*** 0.64-1.28   
* p < 0.05, ** p < 0.01, *** p < 0.001 
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Figure 1. Flow chart illustrating the identification of included studies
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Chapter 3: 
Preventing Postpartum Depression: A Meta-Analytic Review 
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Abstract 
This meta-analysis assessed the efficacy of a wide range of preventive interventions 
designed to reduce the severity of postpartum depressive symptoms or decrease the 
prevalence of postpartum depressive episodes. A systematic review identified 37 
randomized or quasi-randomized controlled trials in which an intervention was compared 
to a control condition. Differences between treatment and control conditions in the level 
of depressive symptoms and prevalence of depressive episodes at 6 months postpartum 
were assessed in separate analyses. Depressive symptoms were significantly lower at 
post-treatment in intervention conditions as compared to control conditions, with an 
overall effect size in the small range after exclusion of outliers (Hedges’ g = 0.18). There 
was a 27% reduction in the prevalence of depressive episodes in intervention conditions 
compared to control conditions at 6 months postpartum, OR = 0.73, after removal of 
outliers and correction for publication bias. Later timing of postpartum assessments was 
associated with smaller differences between intervention and control conditions in both 
analyses. Among studies that assessed depressive symptoms using the EPDS, higher 
levels of depressive symptoms at pre-treatment were associated with smaller differences 
in depressive symptoms between treatment and control conditions at 6 months 
postpartum. No other moderators were identified in either analysis. These findings 
suggest that interventions designed to prevent postpartum depression effectively reduce 
levels of postpartum depressive symptoms and decrease risk for postpartum depressive 
episodes.  
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Preventing Postpartum Depression: A Meta-Analytic Review 
 While the goal of treatment is to alleviate symptoms among individuals 
experiencing a given disorder, preventive interventions are intended to avoid the initial 
onset of disorder. Emotional and behavioral difficulties are commonly identified and 
treated only after the onset of illness, but prevention of these disorders can significantly 
reduce the human and economic costs associated with mental illness (National Research 
Council & Institute of Medicine, 2009). A recent review of progress that has been made 
in the field of depression prevention identified the implementation of interventions with 
strong evidence of effectiveness as a major goal for ongoing research in this area 
(Muñoz, Beardslee, & Leykin, 2012). In order for this goal to be reached, it is necessary 
to identify characteristics of effective preventive interventions.  
 Postpartum depression is a specific mental disorder for which preventive 
interventions could yield dramatic benefits. Depression is one of the most common 
complications of childbearing; a meta-analytic review found that approximately 13% of 
women will experience a major depressive episode during the first postpartum year 
(O’Hara & Swain, 1996). According to the World Health Organization, depression is the 
leading cause of disability worldwide (WHO, 2012). Children of mothers with 
postpartum depression are at increased risk for long-term cognitive impairment, 
emotional difficulties, and behavioral problems (Grace, Evindar, & Stuart, 2003).  
 The context in which postpartum depression occurs provides unique opportunities 
for preventive interventions. Women with fewer financial resources may have greater 
access to healthcare during pregnancy than during other points in the lifespan; for 
example, in the United States, women are eligible for Medicaid during pregnancy and the 
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first 60 days postpartum (Centers for Medicare and Medicaid Services, 2012). More 
generally, pregnancy is a time of increased healthcare utilization, which provides 
opportunities for screening and intervention. Research has identified demographic groups 
at high risk for postpartum depression, such as minority women and women of low 
socioeconomic status, which may be used to target women at increased risk for the 
disorder (Beck, 1996; O’Hara & Swain, 1996). Finally, there is some evidence that 
preventive interventions may be more acceptable, particularly among African-American 
women, than treatment for depression (Crockett, Zlotnick, Davis, Payne & Washington, 
2008).  
 A wide range of interventions for preventing postpartum depression have been 
assessed in randomized controlled trials. Many preventive interventions have modified 
treatments demonstrated to be effective for postpartum depression. For example, 
psychotherapy – particularly cognitive-behavioral and interpersonal psychotherapy – and 
antidepressant medication have all been shown to be effective in the treatment of 
postpartum depression (Sockol, Epperson, & Barber, 2011). Some studies have assessed 
whether implementation of these interventions before the onset of a depressive episode 
can effectively prevent the disorder (e.g., Austin et al., 2008; Wisner, Perel, Peindl, 
Hanusa, Findling & Rapport, 2001; Zlotnick, Capezza, & Parker, 2011). Non-therapeutic 
social support and educational interventions have also been assessed as preventive 
interventions (e.g., Dennis et al., 2009). Other research has investigated whether 
modifications to standard postpartum care, such as having women attend their first 
postpartum checkup at 1 week instead of 6 weeks postpartum, can reduce the incidence 
of depression after childbirth (Gunn, Lumley, Chondros & Young, 1998). Alternative 
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approaches to treatment, notably dietary supplements and hormonal interventions, have 
also been assessed as potential preventive interventions for postpartum depression (e.g., 
Lawrie, Hofmeyr, De Jager, Berk, Paiker & Viljoen, 1998; Llorente, Jensen, Voigt, 
Fraley, Berretta & Heird, 2003). Given the wide range of approaches that have been 
utilized in prevention research, a comprehensive review of the research in this area is 
needed to provide clinicians and researchers with important information regarding the 
absolute and relative efficacy of these interventions.  
 While a great number of reviews of the literature on the prevention of postpartum 
depression have been published, most of these reviews are qualitative in nature (e.g., 
Boath, Bradley, & Henshaw, 2005; Dennis, 2004a; Dennis, 2004b). Several quantitative 
systematic reviews have attempted to synthesize prior findings in this area. Lumley, 
Austin, and Mitchell (2004) reviewed studies initiated during pregnancy and the 
postpartum period; their meta-analysis found that only indicated postnatal interventions 
were associated with decreased risk for postpartum depression. This meta-analysis did 
not assess possible moderators of effect sizes. In another quantitative review, Dennis 
(2005) conducted a meta-analysis of 15 psychological and psychosocial interventions for 
preventing postpartum depression. These analyses found that prevention programs did 
not significantly reduce risk for postpartum depression. However, analyses of moderators 
suggested that interventions were more effective when they targeted women at increased 
risk, when they included a postnatal component, and when they were administered 
individually. In their review of hormonal interventions for preventing and treating 
postpartum depression, Dennis, Ross, and Herxheimer (2009) identified only one study in 
which hormones were utilized as a preventive intervention. Similarly, a review of 
115 
 
 
antidepressant prevention of postnatal depression identified only two studies in which 
medication was utilized for prevention, rather than treatment, of postpartum depression 
(Howard, Hoffbrand, Henshaw, Boath, & Bradley, 2009). A protocol for a review of 
dietary supplements for preventing postpartum depression has been published, but the 
review has yet to be conducted (Miller, Murray, Beckmann, Kent, & Macfarlane, 2011).  
 Overall, existing meta-analyses suggest that preventive interventions for 
postpartum depression may have limited efficacy. However, these analyses have several 
limitations. Each of these analyses was limited to a single type of intervention (e.g., 
psychosocial, hormonal, pharmacological), which precludes the comparison of these 
approaches. With the exception of the Dennis (2005) meta-analysis, these studies have 
not assessed elements of study design or interventions as potential moderators of the 
efficacy of these interventions. These studies also fail to specify the timing of the 
postpartum assessments that were used to calculate the effect sizes. A meta-analytic 
review of depression during the perinatal period found that the prevalence of this disorder 
decreases after seven months postpartum, which suggests that the timing of evaluation 
should be considered when evaluating the efficacy of prevention programs (Gavin, 
Gayner, Lohr, Meltzer-Brody, Gartlehner, & Swinson, 2005).  
 The present meta-analysis addresses several limitations of the above studies. We 
included a wide range of interventions, which allows for the direct comparison of the 
efficacy of different approaches. We included interventions other than antidepressant 
medication and psychotherapy, as there is evidence that women may prefer alternative 
treatments during pregnancy and the postpartum period (Uebelacker, Epstein-Lubow, 
Gaudiano, Tremont, Battle, & Miller, 2010). In order to assess whether these alternative 
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interventions are as effective as empirically supported treatments, we elected to include 
as wide a range of preventive interventions as was possible. We limited our analyses to 
those in which postpartum depression was assessed within the first 6 months postpartum. 
We assessed characteristics of included studies and interventions as potential moderators 
of effect size. We also included several studies that have been published since earlier 
meta-analyses were conducted. The goal of the current meta-analysis was to assess the 
efficacy of a range of preventive interventions for postpartum depression. We assessed 
both the level of depressive symptoms in treatment conditions compared to control 
conditions and the difference in the prevalence of depressive episodes at six months 
postpartum.  
Method 
Search Procedures and Selection of Studies 
 Relevant studies were identified through searches of PsycInfo and PubMed 
through April 2012 using postpartum depression and prevention as keyword search 
terms. The reference lists of existing meta-analyses, relevant reviews, chapters, and 
retrieved articles were inspected for further relevant studies. Clinical trial databases 
(including the Cochrane Pregnancy and Childbirth Group, Cochrane Depression, Anxiety 
and Neurosis Group, and the International Standard Randomised Controlled Trial 
Number Register) were also reviewed for eligible studies.  
To be included in the meta-analysis, studies had to meet the following inclusion 
criteria: 
(a) Study design included intervention and control group(s). Both randomized and quasi-
randomized controlled trials were eligible for inclusion.  
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(b) Authors specified that the goal of the intervention was to reduce postpartum 
depressive symptoms and/or the prevalence of postpartum major depressive episodes. 
Interventions that did not explicitly target depressive symptoms, such as smoking 
cessation programs, were excluded, even if authors reported outcome data for 
depressive symptoms and/or major depressive episodes. Interventions in which 
maternal depression was not the primary outcome of interest, such as studies of infant 
development, were excluded. Interventions designed to treat postpartum depression 
were excluded. Interventions were classified as treatment studies if all subjects met 
criteria for a major depressive episode at pre-treatment or if all subjects had 
depressive symptoms above a cutoff indicative of clinically significant depressive 
symptoms at pre-treatment. 
(c) Intervention was initiated during pregnancy or within 4 weeks of childbirth.  
(d) Reported outcomes for depressive symptoms and/or prevalence of depressive 
episodes between 1 and 6 months postpartum using a validated self-report or 
clinician-administered measure. 
(e) Reported sufficient outcomes to allow for the calculation effect size(s). 
A flow chart summarizing the search process and exclusion of studies is presented 
in Figure 1. After removal of duplicates, the search procedure yielded 797 studies, of 
which 117 studies were obtained and reviewed for inclusion. Of these 117 studies, 80 
were excluded for the following reasons: 17 studies were excluded because the target 
outcome of the intervention was not depressive symptoms or depression diagnosis, 16 
were excluded because they were not randomized or quasi-randomized controlled trials, 
14 studies were excluded because they did not report outcome data or reported 
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insufficient data for the calculation of effect sizes, 11 were excluded because the 
intervention was initiated after 4 weeks postpartum, 5 were excluded because they did not 
include a postpartum assessment between 1 and 6 months postpartum, 4 were excluded 
because they were treatment studies in which subjects were selected on the basis of 
depressive symptoms and/or diagnosis, and 1 was excluded because the measure of 
depressive symptoms was not validated. Secondary manuscripts were identified for 12 
studies; all original manuscripts provided sufficient information for coding and 
calculation of effect sizes so these were not utilized. The remaining 37 articles were 
eligible for inclusion in the meta-analysis. Twenty-four studies reported sufficient 
outcome measures for calculation of effect sizes representing the difference in depressive 
symptoms between treatment and control conditions at 6 months postpartum, and 28 
studies reported sufficient outcome measures for calculation of effect sizes representing 
the difference in prevalence of depressive episodes at 6 months postpartum.   
Coding of Studies 
 All studies were coded for intervention type (dietary supplement vs. educational 
vs. hormonal vs. medication vs. modified care vs. therapy vs. social support). 
Interventions were classified as educational when the intervention consisted of providing 
information, either verbal or written, regarding postpartum depression and accessing 
treatment without actively engaging participants in activities designed to change behavior 
or mood. Interventions were coded as therapy when they were clinician-led and 
participants were engaged in activities with a goal of modifying behavior, cognition, or 
mood. Interventions in which participants were provided with nonspecific support were 
coded as social support interventions. For moderator analyses, interventions were also 
119 
 
 
coded as biological interventions (dietary supplement, hormonal, and medication) or 
psychosocial interventions (educational, modified care, therapy, and social support) and 
as established treatments for postpartum depression (cognitive-behavioral therapy, 
interpersonal psychotherapy, and antidepressant medication) and non-established 
treatments for postpartum depression (dietary supplements, educational interventions, 
hormonal interventions, modified care, other psychotherapies, and social support).  
Studies were also coded for type of control group (active vs. educational vs. 
placebo vs. treatment-as-usual), timing of intervention (pregnancy vs. labor vs. 
postpartum), outcome measure, and timing of postpartum assessment (in weeks). The 
type of prevention study was classified using the criteria proposed by the Institute of 
Medicine report on prevention research (Mrazek & Haggerty, 1994): indicated 
interventions target individuals with subclinical symptoms who do not meet diagnostic 
criteria, selected interventions target individuals with risk factors for a disorder but 
without symptoms of the disorder, and universal interventions are administered to all 
members of a given population.  While a conservative definition of preventive 
interventions would have required us to exclude studies in which subjects were 
experiencing major depressive episodes at pre-treatment, over a third of the potential 
studies either did not assess for the presence of a major depressive episode at pre-
treatment or did not exclude subjects on the basis of a positive screening. Given the large 
number of studies that would have been excluded on the basis of this criterion, we elected 
to include these studies and to assess this as a potential moderator of effect size (excluded 
subjects with MDE at pre-treatment vs. did not assess/did not exclude subjects with MDE 
at pre-treatment). We also coded the average level of depressive symptoms at pre-
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treatment across treatment and control conditions.  
Because studies did not consistently report sample characteristics (ethnicity, 
parity, and marital status), these variables were not coded.  
The only intervention type for which enough studies were included to assess 
potential moderators of effect size was therapeutic interventions. These studies were also 
coded for therapeutic orientation (cognitive-behavioral therapy vs. eclectic vs. 
interpersonal psychotherapy), whether therapy was conducted individually or in a group 
format, and the number of therapy sessions.  
Effect sizes were calculated using the study’s designated primary outcome 
measure. When more than one postpartum assessment was conducted between 1 and 6 
months postpartum, the latest assessment point was used.  
Analyses 
 Two separate analyses were conducted. The first analysis compared the difference 
in depressive symptoms at 6 months postpartum between treatment and control 
conditions using the standardized mean group difference. While this effect size does not 
account for possible differences in depressive symptoms between treatment and control 
conditions at pre-treatment, too few studies reported pre-treatment depressive symptoms 
for effect sizes that take these potential differences into account to be calculated. Effect 
sizes were calculated by dividing the difference between treatment and control means by 
the pooled standard deviation, corrected for upward bias using Hedges’ g (Hedges, 1981):
 
     [
     
   
] 
121 
 
 
where the pooled standard deviation is defined as 
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Effect sizes were calculated so that positive effect sizes represent lower scores in the 
intervention group compared to the control group.  
 The second analysis compared the prevalence of depressive episodes at 6 months 
postpartum between treatment and control conditions using the odds ratio:  
    
       )
       )
 
Where PT is the proportion of depressed subjects in treatment conditions and PC is the 
proportion of depressed subjects in treatment conditions. Odds ratios less than 1 indicate 
lower rates of depression among treated conditions compared to control conditions.  
The heterogeneity of effect sizes was examined using the Q statistic and the I
2
 
index. Significant Q statistics indicate that the observed range of effect sizes is 
significantly larger than would be expected based on within-study variance. The I
2
 value 
indicates the proportion of variance in effect sizes accounted for by between-study 
variance. The index has a range from 0 to 100; Higgins and colleagues (2003) suggest 
that 25, 50 and 75% I
2
 values indicate low, medium and high levels of hetereogeneity, 
respectively. When analyses indicated significant heterogeneity among effect sizes, 
exploratory analyses were conducted to assess for moderators of effect size. Categorical 
moderators were assessed using an analysis of variance (ANOVA) of mixed-effects 
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models for each variable hypothesized to influence the effect size. Meta-regression 
analyses were conducted to assess the effects of continuous moderators.    
 Publication bias was assessed by visual examination of funnel plots, Duval and 
Tweedie’s (2000) trim-and-fill procedure, and classic fail-safe N values (Rosenthal, 
1979). First, the effect size for each study was plotted against the study standard error. An 
asymmetric distribution suggests missing studies due to publication bias (Lipsey & 
Wilson, 2001). We used Duval and Tweedie’s trim-and-fill procedure (2000) to identify 
asymmetric distributions of effect sizes. When this test indicated significant asymmetry 
in the funnel plot, the overall estimates for the model were calculated using the trim-and-
fill correction (Duval & Tweedie, 2000). Using the fail-safe N value, we determined the 
number of studies with null findings that would be necessary to produce a nonsignificant 
overall effect size. Using Rosenthal’s (1991) recommendation, a value of 5K + 10, where 
K is the number of observed studies, was used as the cutoff for an unlikely number of 
studies.   
For each of these analyses, outliers were identified using the sample-adjusted 
meta-analytic deviance (SAMD) statistic (Huffcutt & Arthur, 1995). A conservative 
cutoff score of 2.58 was used to consider studies for exclusion from the analyses, since 
extreme values can result from either true population variability or error, and removing 
outliers whose effects represent true variability limits the ability to assess the role of 
moderators (Beal, Corey & Dunlap, 2002). The SAMDs were rank-ordered and the scree 
plots examined to confirm the outlier status of studies with SAMDs above this cutoff. In 
cases where the SAMD value was greater than 2.58 but the scree plot suggested that the 
SAMD was not discrepant from the overall distribution, the study was retained to 
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maximize the variance available to assess the role of moderators. 
Calculations of weighted mean effect sizes, heterogeneity, and moderators were 
conducted using Comprehensive Meta-Analysis, version 2.2.046 (Borenstein, Hedges, 
Higgins, & Rothstein, 2005). We estimated overall effect sizes using random effects 
models, based on the assumption that the included studies represent a distribution of true 
intervention effects. Considerable heterogeneity of effect sizes was expected given the 
differences in interventions and samples across the included studies. As the Q statistic is 
underpowered in cases of small sample size (Lipsey & Wilson, 2001), random effects 
models were estimated regardless of the observed heterogeneity. 
Results 
Characteristics of Included Studies 
 Table 1 presents characteristics of the studies included in the analyses. Studies 
included a wide range of intervention types, including therapy (n = 18), modified care (n 
= 6), social support (n = 6), antidepressant medication (n = 2), educational programs (n = 
2), dietary supplements (n = 2), and hormonal interventions (n = 1). Control group types 
included treatment-as-usual (n = 24), educational programs (n = 7), placebo (n = 5), and a 
nonspecific active treatment (n = 1). Interventions were initiated during pregnancy (n = 
23), the first four weeks postpartum (n = 13), or during labor (n = 1). Prevention types 
included indicated interventions (n = 3), selected/indicated interventions (n = 9), selected 
interventions (n = 12), and universal interventions (n = 13). The timing of the postpartum 
assessment ranged from 4 to 24 weeks, with the average assessment taking place at 14.6 
weeks postpartum (SD = 6.7).  
 Characteristics of therapy interventions. Eighteen studies assessed therapeutic 
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interventions. One study assessed training in guided relaxation provided via videotape; 
this study was excluded from moderator analyses of therapy characteristics due to 
differences in the method of administration of the intervention. The remaining studies 
assessed cognitive-behavioral (n = 10), interpersonally-oriented (n = 5), and eclectic (n = 
2) interventions. Studies included both group therapy (n = 10) and individually-
administered therapy (n = 7). The average number of therapy sessions was 5.9 (SD = 3.0).  
Methodological Quality 
 Table 2 presents characteristics of the included studies related to methodological 
quality. Two studies were quasi-randomized trials; the remaining 35 studies were 
randomized controlled trials. 62% of studies reported results on the basis of intent-to-treat 
analyses. 95% of studies provided some information characterizing the included sample. 
28% of studies excluded participants with current major depressive episodes. Of the 19 
studies that included a clinician-administered measure, 63% reported that assessors were 
blind to treatment status. Of the 35 randomized controlled trials, 83% specified the 
method by which participants were randomized.  
 Methodological quality of therapy interventions. Eighteen studies included 
therapeutic interventions. One of these interventions was provided via videotape. Of the 
remaining 17 studies, 83% provided information about the therapists who provided the 
intervention, 56% indicated that an intervention manual was utilized, 78% indicated that 
therapists received training in the intervention, 67% indicated that therapists received 
supervision during the study, and 44% assessed sessions for adherence to the 
intervention.  
 Methodological quality of pharmacological interventions. Five studies 
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included pharmacological interventions (antidepressant medication, dietary supplements, 
or hormonal interventions). For these studies, 80% reported that clinicians were blind to 
treatment status and 100% reported that participants were blind to treatment status.  
Postpartum Depressive Symptoms 
 Table 3 presents the results of the random effects model for postpartum 
depressive symptoms, representing results from 24 studies. These effect sizes represent 
the difference between depressive symptoms at the postpartum assessment closest to 6 
months postpartum; positive effect sizes indicate superiority of treatment to control 
conditions. Effect sizes (Hedges’ g) ranged from -0.20 to 12.10; eight studies had 
significant effect sizes, all in favor of the treated condition. There was a significant 
overall effect of treatment (g = 0.37, 95% CI 0.15-0.60, p < 0.001). Two studies had 
SAMD values greater than 2.58. Visual inspection of the scree plot of the rank-ordered 
SAMD scores suggested that the SAMD values for the studies by Small and colleagues 
(2000) and Wolman and colleagues (1993) were discrepant with the overall distribution 
of SAMD scores. These studies were excluded from subsequent analyses; the average 
effect size excluding these outliers was g = 0.18 (95% CI 0.09-0.27, p < 0.001).  
 We also used meta-analysis to assess the average level of depressive symptoms at 
six months postpartum in treatment and control conditions. In the 14 studies that utilized 
the EPDS as a measure of depressive symptoms, the average EPDS score was 7.06 in 
treatment conditions, compared to 7.69 in control conditions. In the five studies that used 
the BDI-II as a measure of depressive symptoms, the average BDI score was 8.99 in 
treatment conditions, compared to 8.55 in control conditions. In the two studies that used 
the CES-D as a measure of depressive symptoms, the average CES-D score was 1.49 in 
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treatment conditions, compared to 1.57 in control conditions.  
Results of tests for publication bias were acceptable. The fail-safe N value was 
129, which exceeds the tolerance value of 120. While the funnel plot was slightly 
asymmetric (see Figure 2); trim-and-fill procedures suggested no missing studies. The Q 
statistic indicated that there was significant heterogeneity among effect sizes (p < 0.05). 
The I
2
 value indicated a medium level of heterogeneity, with 37% of the variance in 
effect sizes attributable to between-study variance (Higgins et al., 2003).  
Moderator Analyses: Postpartum Depressive Symptoms 
 Because both the Q statistic and I
2 
index indicated significant heterogeneity of 
effect sizes, exploratory analyses of potential moderators were conducted. Subgroups 
including only one study were excluded from moderator analyses.  
 Study characteristics. Nine characteristics of the included studies were assessed 
as potential moderators: intervention type (general, biological vs. psychosocial, and EST 
vs. non-EST), control group type, timing of intervention, type of prevention, measure, 
whether the study excluded women with a current major depressive episode, timing of 
postpartum assessment, and average pre-treatment depressive symptoms (see Table 4). 
No categorical variables were significant moderators of effect size. There was a trend for 
later assessment timing was associated with smaller effect sizes; slope = -0.01, p = 0.05. 
In studies that assessed depressive symptoms using the EPDS, higher levels of depressive 
symptoms at pre-treatment were associated with smaller effect sizes, slope = -0.07, p < 
0.01. There was no relationship between depressive symptoms at pre-treatment and effect 
size in studies that assessed depressive symptoms using the BDI-II, slope = 0.01, p > 
0.05.  
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 Intervention variables. Three characteristics of interventions for studies 
assessing psychotherapeutic interventions were assessed as potential moderators: 
therapeutic orientation, method of administration, and number of sessions. There were 
not enough studies representing other types of interventions to assess moderators for 
these interventions. No categorical characteristics of psychotherapeutic interventions 
were significant moderators of effect size. There was a trend for studies with more 
therapy sessions to have smaller effect sizes; slope = -0.04, p = 0.06.  
Postpartum Depression Diagnosis 
 Table 5 presents the results of the random effects model for postpartum 
depression diagnoses, representing results from 28 studies. Odds ratios for individual 
studies ranged from 0.02 to 1.79. Odds ratios were significant for eight individual studies; 
seven in favor of the treated condition and one in favor of the control condition. There 
was a significant overall positive effect of treatment (OR = 0.72, 95% CI 0.0.56-0.94, p = 
0.01), representing a 28% reduction in risk for postpartum depression in treatment groups 
compared to control groups. Nine studies had SAMD values greater than 2.58. Visual 
inspection of the scree plot of the rank-ordered SAMD scores indicated that the value for 
the studies by Kozinszky and colleagues (2012) and Small and colleagues (2000) were 
discrepant. These studies were excluded from subsequent analyses. The average effect 
size, excluding these outliers, was OR = 0.67 (95% CI 0.52-0.85, p < 0.01), which 
represents a 33% reduction in risk for treatment groups compared to control groups.  
Results of tests for publication bias indicated potential bias in the included 
studies. The fail-safe N value was 147, which exceeds the tolerance limit of 140. The 
funnel plot was asymmetric (see Figure 3), and the trim-and-fill correction suggested 5 
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studies missing to the right of the mean. After correction for publication bias, the overall 
effect size was 0.73 (95% CI 0.56-0.95), which represents a 27% reduction in the risk for 
treatment groups compared to control groups. The Q statistic indicated that there was 
significant heterogeneity among the effect sizes (p < 0.01). The I
2 
value indicated a 
medium level of heterogeneity, with 46% of the variance in effect sizes attributable to 
between-study variance (Higgins et al., 2003).  
Moderator Analyses: Postpartum Depression Diagnosis 
Study characteristics. Ten characteristics of the included studies were assessed 
as potential moderators: intervention type (general, biological vs. psychosocial, and EST 
vs. non-EST), control group type, timing of intervention, type of prevention, method of 
diagnosing depression, whether the study excluded women with a current major 
depressive episode, timing of postpartum assessment, and baseline depressive symptoms 
(see Table 6). No categorical variables were significant moderators of effect size. Studies 
with later assessments had larger effect sizes, slope = 0.02, p < 0.05. There was no 
relationship between depressive symptoms at pre-treatment and effect size in studies that 
assessed depressive symptoms using the EPDS, slope = 0.04, p > 0.05. 
 Intervention variables. Three characteristics of interventions for studies 
assessing psychotherapeutic interventions were assessed as potential moderators: 
therapeutic orientation, method of administration, and number of sessions. There were 
not enough studies representing other types of interventions to assess moderators for 
these interventions. None of these variables was a significant moderator of effect size.  
Discussion 
 Results of these meta-analyses suggest that a wide range of interventions may be 
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effective in the prevention of depression during the first 6 months postpartum. These 
interventions result in small but significant reductions in depressive symptoms (g = 0.18) 
and the prevalence of depressive episodes (OR = 0.73). Although the magnitude of the 
effects of preventive interventions are modest compared to treatments for postpartum 
depression, which a previous meta-analysis found to be in the medium range (g = 0.65, 
Sockol, Epperson, & Barber, 2011), the efficacy of these interventions is comparable to, 
or exceeds, the efficacy of preventive interventions for anxiety and depression from other 
meta-analyses (Cuijpers, van Straten, Andersson & van Oppen, 2008; Zalta, 2011). The 
overall level of depressive symptoms at six months postpartum in both treatment and 
control conditions were below generally accepted cutoffs for clinically significant 
depressive symptoms (Cox, Chapman, Murray & Jones, 1996; Dozois & Dobson, 2002).  
 For both depressive symptoms and depression diagnosis, a later assessment was 
associated with a smaller difference between intervention and control conditions. This is 
consistent with the results of a meta-analysis of treatments for postpartum depression, 
which found that treatment length was associated with smaller effect sizes (Sockol, 
Epperson, & Barber, 2011). Moreover, it is consistent with evidence that postpartum 
depression tends to naturally remit over time (Heron et al., 2004). Given that the natural 
course of postpartum depression is for symptom severity to decrease over time, it is 
unsurprising that preventive interventions appear to be most efficacious when they are 
assessed early during the postpartum period. However, this should not be taken as an 
indication that preventive interventions are unnecessary. Given the adverse impact of 
depression on depressed women and their children, even a self-limiting depressive 
episode may be extremely distressing and increase the risk for long-term negative 
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outcomes.  
Higher levels of depressive symptoms at pre-treatment were associated with 
smaller differences in depressive symptoms at six months postpartum between treatment 
and control conditions in studies that used the EPDS as a measure of depressive 
symptoms. As this result was only found in one of our analyses, and for only one measure 
of depressive symptoms, this result should be interpreted with caution. However, if this 
finding represents a true difference in the efficacy of preventive interventions, this 
suggests that preventive interventions might be more effective for women who are not yet 
experiencing significant levels of depressive symptoms. The duration or intensity of 
preventive interventions may not be sufficient to prevent the onset of depressive episodes 
or worsening of symptoms among this population.  
 Interestingly, we found that intervention type was not related to the effectiveness 
of treatments for either reducing depressive symptoms or preventing depressive episodes. 
A lack of social support is an established risk factor for postpartum depression (Beck, 
1996). It may be that nonspecific social contact and support is sufficient for reducing risk 
for depression among this population and that the specific active elements of treatment 
are less important. However, further research assessing the efficacy of less well-studied 
interventions is necessary to determine whether our failure to identify moderators simply 
results from a lack of sufficient evidence. Given the small number of studies representing 
antidepressant medication and non-traditional interventions, particularly dietary 
supplements and hormonal interventions, further research is necessary to establish 
whether these approaches are truly equally efficacious.  
One limitation of this meta-analysis was the use of uncontrolled effect sizes. This 
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raises the concern that differences at post-treatment may actually reflect pre-existing 
differences between treatment and control conditions. A separate meta-analysis was 
conducted assessing the average change in depressive symptoms from pre-treatment to 
post-treatment between treatment and control conditions using the standardized mean 
gain score using the 13 studies for which this effect size could be calculated. The fail-safe 
N for this analysis was 17, which is well below the tolerance value, so the results should 
be interpreted with caution. With this caveat, this analysis also found a small but 
significant difference in the reduction in depressive symptoms between treatment and 
control conditions, Hedges’ g = 0.15, p = 0.01, 95% CI 0.03-0.27. The results of this 
analysis suggest that our findings are unlikely to simply reflect pre-existing differences 
between treatment and control conditions.  
While the number of studies included in these meta-analyses is comparable to 
other meta-analyses of preventive interventions (e.g., Cuijpers et al., 2008; Zalta, 2011), 
moderator analyses assessed small subgroups of studies. Because of this, moderator 
analyses should be interpreted with caution. This is particularly true for the analyses of 
intervention type. There were relatively few studies assessing antidepressant medication, 
dietary supplements, educational interventions, hormonal interventions, and social 
support programs. More research assessing the efficacy of these interventions is 
necessary in order to establish whether there are systematic differences between types of 
interventions. Similarly, psychotherapy was the only type of intervention for which 
enough studies were present to assess for potential moderation of specific aspects of the 
intervention. Further evaluation of other types of interventions would allow for similar 
questions to be asked of these interventions; for example, whether phone-based social 
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support programs have comparable efficacy to in-person support groups.   
 A major concern raised by these analyses is the evidence that published studies 
are biased in favor of studies with significant positive findings. While the overall effect 
for preventive interventions remained significant even after correction for publication 
bias, there is no statistical approach that can take the place of real data for moderator 
analyses. While our analyses found no evidence that types of interventions or 
characteristics of interventions were associated with efficacy, it is possible that there are 
systematic characteristics of ineffective interventions that we were unable to assess 
because these results have not been published. This may have limited our ability to 
identify moderators of effect size. While the “file-drawer problem” is well-known, these 
analyses provide further evidence that null findings from well-designed prevention 
studies are vitally important to a full understanding of these interventions.  
In summary, these analyses suggest that a wide range of interventions are 
effective in the prevention of postpartum depression. At six months postpartum, these 
interventions are associated with a 27% reduction in the prevalence of depressive 
episodes and a reduction in levels of depressive symptoms compared to control 
conditions. Effect sizes were larger in studies that assessed depression earlier in the 
postpartum period; this is consistent with natural remission of depressive symptoms over 
the course of the postpartum period. There were no differences between types of 
interventions, and different types of psychotherapeutic interventions appeared to have 
comparable efficacy. There were few studies assessing antidepressant medication and 
other non-therapeutic interventions; more research is necessary to assess whether these 
interventions are effective and to establish whether characteristics of other intervention 
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types are related to efficacy. Although more research is needed to confirm and extend the 
results of these meta-analyses, these results suggest that a wide range of interventions 
should be targeted for further investigation as preventive interventions for this disorder.  
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Table 1 
 
Characteristics of Included Studies 
 
Study Country 
Intervention 
Type 
Control 
Type 
Intervention 
Timing 
Prevention 
Type 
Symptom 
Measure 
Diagnosis 
Criteria 
Postpartum 
Assessment 
Timing 
(Weeks) 
Psychotherapy 
Orientation 
Psychotherapy 
Administration 
Number of 
Sessions 
Armstrong et al. 
(1999) 
AUS Modified 
Care 
TAU POST Selected EPDS EPDS > 12 6    
Austin et al.  
(2008) 
AUS Therapy EDUC PREG Selected/ 
Indicated 
 MINI 16 CBT Group 6 
Brugha et al. 
(2000) 
UK Therapy TAU PREG Selected/ 
Indicated 
 SADS 12 CBT Group 6 
Chabrol et al. 
(2002) 
FR Therapy TAU POST Indicated EPDS EPDS > 11 4-6 CBT Individual 1 
Dennis et al. 
(2009) 
CAN Social 
Support 
TAU POST Indicated EPDS EPDS > 12 24    
Elliott et al.  
(2000) 
UK Social 
Support 
TAU PREG Selected  PSE 12    
Gao, Chan, & Sun 
(2012) 
CHINA Therapy EDUC PREG Universal EPDS  12 IPT Group 2 
Gorman  
(1997) 
USA Therapy TAU PREG Selected/ 
Indicated 
EPDS SCID 24 IPT Individual 5 
Gunn et al.  
(1998) 
AUS Modified 
Care 
TAU POST Universal EPDS EPDS ≥ 13 24 
 
   
Hagan, Evans, & 
Pope (2004) 
AUS Therapy EDUC POST Selected  SADS 24 CBT Group 6 
Hayes, Muller, & 
Bradley (2001) 
AUS Educational TAU PREG Universal POMS  16-24    
Ho et al.  
(2009) 
CHINA Educational TAU POST Universal EPDS  12    
Kozinszky et al. 
(2012) 
HUN Therapy EDUC PREG Universal  LQ ≥ 12 6-8 Eclectic Group 4 
Lara, Navarro, & 
Navarrete (2010) 
MEX Therapy EDUC PREG Selected/ 
Indicated 
 SCID 16-24 Eclectic Group 8 
Lawrie et al. 
(1998) 
S AFR Hormonal PLA POST Universal EPDS EPDS ≥ 12 12    
Le, Perry, & Stuart 
(2011) 
USA Therapy TAU PREG Selected/ 
Indicated 
BDI-II BDI-II ≥ 20 16 CBT Group 8 
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Study Country 
Intervention 
Type 
Control 
Type 
Intervention 
Timing 
Prevention 
Type 
Symptom 
Measure 
Diagnosis 
Criteria 
Postpartum 
Assessment 
Timing 
(Weeks) 
Psychotherapy 
Orientation 
Psychotherapy 
Administration 
Number of 
Sessions 
Llorente et al. 
(2003) 
USA Dietary 
Supplement 
PLA POST Universal BDI-II  16    
Logsdon et al. 
(2003) 
USA Social 
Support 
TAU PREG Selected CES-D  6    
Marks, Siddle, & 
Warwick (2003) 
UK Modified 
Care 
TAU PREG Selected/ 
Indicated 
EPDS 
 
SCID 12    
Meeker  
(1985) 
USA Social 
Support 
TAU PREG Universal BDI-II  7    
Milgrom et al. 
(2011) 
AUS Therapy TAU PREG Selected/ 
Indicated 
 BDI-II ≥ 14 12 CBT Individual 
(Phone) 
8 
Mokhber et al. 
(2011) 
IRAN Dietary 
Supplement 
PLA PREG Universal EPDS  8    
Muñoz et al. 
(2007) 
USA Therapy TAU PREG Selected/ 
Indicated 
EPDS 
 
MMS 24 CBT Group 12 
Nalepka & 
Coblentz (1995) 
USA Social 
Support 
EDUC PREG Universal  EPDS ≥ 10 12    
Ngai, Chan, & Ip 
(2009) 
CHINA Therapy EDUC PREG Universal EPDS  24 CBT Group 6 
Rees  
(1995) 
USA Therapy ACT POST Universal CES-D  4 Guided 
Relaxation 
Individual 
(Home) 
N/A 
Shields & Reid 
(1997) 
UK Modified 
Care 
TAU PREG Universal 9 Item 
EPDS 
EPDS > 13 7    
Silverstein et al. 
(2011) 
USA Therapy TAU POST Selected  QIDS ≥ 11 24 CBT Individual 4 
Small et al.  
(2000) 
AUS Modified 
Care 
TAU POST Selected EPDS EPDS ≥ 13 24    
Stamp, Williams, 
& Crowther (1995) 
AUS Social 
Support 
TAU PREG Selected EPDS EPDS > 12 24    
Webster et al. 
(2003) 
AUS Educational TAU PREG Selected  EPDS > 12 16    
Wisner et al. 
(2001) 
USA ADM 
Nortriptyline 
PLA POST Selected  RDC 17    
Wisner et al. 
(2004) 
USA ADM 
Sertraline 
PLA POST Selected  DSM-IV 17    
Wolman et al. 
(1993) 
S AFR Modified 
Care 
TAU BIRTH Universal PITT PITT ≥ 35 6    
Zayas, McKee, & 
Jankowski (2004) 
USA Therapy TAU PREG Indicated BDI-II  12 CBT Individual 12 
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Study Country 
Intervention 
Type 
Control 
Type 
Intervention 
Timing 
Prevention 
Type 
Symptom 
Measure 
Diagnosis 
Criteria 
Postpartum 
Assessment 
Timing 
(Weeks) 
Psychotherapy 
Orientation 
Psychotherapy 
Administration 
Number of 
Sessions 
Zlotnick, Capezza, 
& Parker (2011) 
USA Therapy TAU PREG Selected EPDS LIFE 12 IPT Individual 4 
Zlotnick et al. 
(2001) 
USA Therapy TAU PREG Selected/ 
Indicated 
 SCID 12 IPT Group 4 
Zlotnick et al. 
(2006) 
USA Therapy TAU PREG Selected BDI-II LIFE 12 IPT Group 4 
Note. AUS = Australia, CAN = Canada, CHINA = China, FR = France, HUN = Hungary, IRAN = Iran, MEX = Mexico, S AFR = South Africa, UK = United Kingdom, USA = United States, ACT = 
Active, EDUC = Educational, PLA = Placebo, TAU = Treatment As Usual, BIRTH = During labor, POST = Postpartum, PREG = Pregnancy, BDI-II = Beck Depression Inventory, CES-D = Center for 
Epidemiological Studies Depression Scale, DSM-IV = DSM-IV depression criteria, EPDS = Edinburgh Post-Natal Depression Scale, PITT = Pittsburgh Depression Inventory, LIFE = Longitudinal 
Interview Follow-Up Examination, LQ = Leverton Questionnaire, MINI = MINI-International Neuropsychiatric Interview, MMS = Maternal Mood Screener, QIDS = Quick Inventory of Depressive 
Symptomatology, RDC = Research Diagnostic Criteria, SADS = Schedule for Affective Disorders and Schizophrenia, SCID = Structured Clinical Interview for DSM-IV, CBT = Cognitive-Behavioral 
Therapy, IPT = Interpersonal Psychotherapy 
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Table 2 
 
Methodological Quality of Included Studies  
 
      Therapy Pharmacological 
Study ITT 
Char 
Sample 
Excl Curr 
MDE 
Blind 
Assess 
Spec 
Random 
Spec 
Ther Manual Training Super Adher 
Blind 
Clin Blind Pt 
Armstrong et al. (1999) - + - + +        
Austin et al. (2008) + + - + + + + + - -   
Brugha et al. (2000) + + - + + + + + + -   
Chabrol et al. (2002) + + - N/A + + + + + +   
Dennis et al. (2009) + + - N/A +        
Elliott et al. (2000) + - - + QR        
Gao, Chan, & Sun (2012) + + - N/A + + - + + -   
Gorman (1997) - + - + + - + - - +   
Gunn et al. (1998) + + - N/A +        
Hagan, Evans, & Pope (2004) - + + + + + - + + -   
Hayes, Muller, & Bradley (2001) - + + - +        
Ho et al. (2009) - + - N/A +        
Kozinszky et al. (2012) + + - + + + - + - +   
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      Therapy Pharmacological 
Study ITT 
Char 
Sample 
Excl Curr 
MDE 
Blind 
Assess 
Spec 
Random 
Spec 
Ther Manual Training Super Adher 
Blind 
Clin Blind Pt 
Lara, Navarro, & Navarrete (2010) + + + - + + + + + +   
Lawrie et al. (1998) + + - + +      + + 
Le, Perry, & Stuart (2011) + + + - + + + + + +   
Llorente et al. (2003) - + - N/A +      - + 
Logsdon et al. (2003) - + - N/A +        
Marks, Siddle, & Warwick (2003) + + - - +        
Meeker (1985) + + - N/A -        
Milgrom et al. (2011) + + - N/A + + + - + +   
Mokhber et al. (2011) - + + N/A -      + + 
Muñoz et al. (2007) - + + - + + + + + +   
Nalepka & Coblentz (1995) - + - N/A +        
Ngai, Chan, & Ip (2009) + + - N/A QR + - + - -   
Rees (1995) + + - N/A - N/A N/A N/A N/A N/A   
Shields & Reid (1997) - + - N/A -        
Silverstein et al. (2011) + + - + + + + + + +   
Small et al. (2000) + + - N/A +        
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      Therapy Pharmacological 
Study ITT 
Char 
Sample 
Excl Curr 
MDE 
Blind 
Assess 
Spec 
Random 
Spec 
Ther Manual Training Super Adher 
Blind 
Clin Blind Pt 
Stamp, Williams, & Crowther (1995) + + - N/A +        
Webster et al. (2003) + + -  N/A +        
Wisner et al. (2001) + - + + +      + + 
Wisner et al. (2004) + + + + +      + + 
Wolman et al. (1993) - + - + +        
Zayas, McKee, & Jankowski (2004) - + - N/A - + - + + -   
Zlotnick, Capezza, & Power (2011) + + + - + + + + + -   
Zlotnick et al. (2001) - + + - - - - - - -   
Zlotnick et al. (2006) - + + - + + - + + -   
Note. ITT = report intent-to-treat analyses, Char Sample = specify characteristics of sample, Excl Curr MDE = assess for depressive episode pre-treatment and exclude subjects who meet diagnostic 
criteria, Blind Assess = clinician-administered diagnostic measures conducted by independent evaluator blind to treatment condition, Spec Random = specification of method of randomization, Spec 
Ther = specify therapist characteristics, Manual = specify use of therapy manual, Training = describe therapist training, Super = describe therapist supervision, Adher = indicate therapy was assessed for 
adherence to manual, Blind Clin = clinician blind to treatment status, Blind Pt = patient blind to treatment status, + = Yes, - = No, N/A = Not Applicable, QR = Quasi-Randomized
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Table 3 
Random Weighted Effect Sizes (Hedges’ g) Comparing Depressive Symptoms 
Between Treatment and Control Conditions at 6 Months Postpartum 
Study n Hedges’ g 95% CI SAMD  
Armstrong et al. (1999) 181 0.44** 0.14-0.73 1.97  
Chabrol et al. (2002) 211 0.42** 0.15-0.70 2.05  
Dennis et al. (2009) 600 0.13 -0.03-0.29 -0.17  
Gao, Chan, & Sun (2012) 194 0.34* 0.06-0.62 1.39  
Gorman (1997) 30 0.02 -0.68-0.72 -0.33  
Gunn et al. (1998) 475 0.02 -0.16-0.20 -1.38  
Hayes, Muller, & Bradley (2001) 188 0.1 -0.18-0.39 -0.27  
Ho et al. (2009) 168 0.39* 0.09-0.70 1.61  
Lawrie et al. (1998) 168 -0.12 -0.42-0.19 -1.67  
Le, Perry, & Stuart (2011) 174 -0.09 -0.38-0.21 -1.52  
Llorente et al. (2003) 89 -0.15 -0.56-0.26 -1.38  
Logsdon et al. (2003) 109 -0.2 -0.65-0.25 -1.76  
Marks, Siddle, & Warwick (2003) 85 0 -0.42-0.42 -0.65  
Mokhber et al. (2011) 85 0.39 -0.03-0.82 1.15  
Munoz et al. (2007) 41 0.24 -0.36-0.84 0.30  
Ngai, Chan, & Ip (2009) 184 0.42** 0.13-0.71 1.89  
Rees (1995) 60 0.61* 0.10-1.12 1.78  
Shields & Reed (1997) 788 0.18** 0.04-0.32 0.60  
Small et al. (2000)
 1
 917 -0.08 -0.21-0.05 -3.55  
Wolman et al. (1993)
 1
 149 12.10*** 10.69-13.51 70.69  
Zayas, McKee, & Jankowski (2004) 57 0.07 -0.44-0.59 -0.25  
Zlotnick, Capezza, & Parker (2011) 35 0.32 -0.21-0.85 0.86  
Zlotnick et al. (2001) 86 0.44 -0.22-1.10 -0.22  
Zlotnick et al. (2006) 54 0.09 -0.33-0.51 0.64  
 k Hedges’ g 95% CI Q(df) I2 
Total (all studies) 24 0.37*** 0.15-0.60 321.40(23)*** 92.84 
Total (outliers excluded) 22 0.18*** 0.09-0.27 33.32(21)* 36.98 
* p < 0.05, ** p < 0.01, *** p < 0.001 
1 Outlier excluded from subsequent analyses.  
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Table 4 
 
Analyses of Moderation for Depressive Symptoms at 6 Months Postpartum 
 
Moderator N Hedges’ g 95% CI Q(df) p 
Intervention Type    2.73(4) 0.60 
Dietary Supplement 2 0.12 -0.42-0.65   
Educational 2 0.24 -0.04-0.53   
Modified Care 4 0.16 -0.01-0.33   
Therapy 11 0.27*** 0.14-0.40   
Social Support 2 0.04 -0.25-0.33   
Intervention Type    1.06(1) 0.30 
Biological 3 0.02 -0.30-0.35   
Psychosocial 19 0.20*** 0.11-0.29   
Intervention Type    1.56(1) 0.21 
EST 10 0.25*** 0.12-0.38   
Non-EST 12 0.14* 0.03-0.25   
Control Group Type    4.89(2) 0.09 
Educational 2 0.38*** 0.18-0.58   
Placebo 3 0.02 -0.30-0.35   
TAU 16 0.16*** 0.07-0.25   
Intervention Timing    0.06(1) 0.81 
Pregnancy 14 0.18*** 0.09-0.26   
Postpartum 8 0.20* 0.03-0.36   
Type of Prevention    2.17(3) 0.54 
Indicated 3 0.22* 0.01-0.44   
Selected 4 0.18 -0.10-0.47   
Selected/Indicated 5 0.03 -0.11-0.23   
Universal 10 0.19** 0.07-0.32   
Measure    4.34(2) 0.11 
BDI-II 5 0.00 -0.19-0.18   
CES-D 2 0.20 -0.60-.99   
EPDS 13 0.23*** 0.12-0.34   
Exclude Current MDE     0.32(1) 0.58 
No 15 0.19*** 0.08-0.29   
Yes 7 0.13 -0.02-0.29   
Psychotherapy Orientation    0.06(1) 0.80 
CBT 5 0.23 0.00-0.46   
IPT 5 0.27** 0.07-0.47   
Method of Psychotherapy 
Administration    0.39(1) 0.53 
Group 6 0.23* 0.04-0.41   
Individual 4 0.31** 0.11-0.52   
† p < 0.10,* p < 0.05, ** p < 0.01, *** p < 0.001 
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Table 5 
Random Weighted Effect Sizes (Odds Ratio) Comparing Prevalence of Depressive 
Episodes Between Treatment and Control Conditions at 6 Months Postpartum 
Study n OR 95% CI SAMD  
Armstrong et al. (1999) 181 0.24 0.09-0.65 -3.30  
Austin et al. (2008) 277 0.94 0.50-1.76 1.79  
Brugha et al. (2000) 190 0.49 0.12-2.02 -1.54  
Chabrol et al. (2002) 211 0.46 0.26-0.81 -1.95  
Dennis et al. (2009) 600 0.80 0.49-1.31 1.00  
Elliott et al. (2000) 99 0.38 0.15-0.94 -1.73  
Gorman (1997) 37 0.57 0.11-3.03 -0.43  
Gunn et al. (1998) 475 1.26 0.76-2.09 5.63  
Hagan, Evans, & Pope (2004) 192 1.02 0.47-2.23 2.04  
Kozinszky et al. (2012)
 1
 1719 1.79 1.30-2.48 18.00  
Lara, Navarro, & Navarrete (2010) 116 0.36 0.13-1.01 -1.95  
Lawrie et al. (1998) 168 1.13 0.59-2.18 2.60  
Le, Perry, & Stuart (2011) 174 1.38 0.52-3.67 4.18  
Marks, Siddle, & Warwick (2003) 87 1.05 0.41-2.73 1.51  
Milgrom et al. (2011) 89 0.24 0.08-0.69 -2.31  
Munoz et al. (2007) 41 0.17 0.01-3.82 -1.68  
Nalepka & Coblentz (1995) 72 0.94 0.18-4.98 0.88  
Shields & Reid (1997) 788 0.66 0.47-0.94 -0.70  
Silverstein et al. (2011) 42 0.40 0.11-1.51 -1.01  
Small et al. (2000)
 1
 917 1.26 0.88-1.80 7.39  
Stamp, Williams, & Crowther (1995) 121 1.62 0.54-4.89 4.79  
Webster et al. (2003) 369 0.80 0.50-1.28 0.81  
Wisner et al. (2001) 51 0.95 0.26-3.45 0.77  
Wisner et al. (2004) 22 0.08 0.01-0.90 -1.44  
Wolman et al. (1993) 149 0.02 0.00-0.40 -4.17  
Zlotnick, Capezza, & Parker (2011) 35 1.68 0.36-7.86 2.68  
Zlotnick et al. (2001) 86 0.06 0.00-1.08 -3.00  
Zlotnick et al. (2006) 54 0.17 0.03-0.88 -2.01  
 k OR 95% CI Q(df) I
2
 
Total (all studies) 28 0.72* 0.56-0.94 74.83(27)*** 63.92 
Total (outliers excluded) 26 0.67** 0.52-0.85 45.95(25)** 45.60 
Total (trim-and-fill correction)  0.73* 0.56-0.95 61.93  
* p < 0.05, ** p < 0.01, *** p < 0.001 
1 Outlier excluded from subsequent analyses.  
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Table 6 
 
Analyses of Moderation for Depressive Episodes at 6 Months Postpartum 
 
Moderator n OR 95% CI Q(df) p 
Intervention Type    1.13(3) 0.77 
Medication 2 0.34 0.03-3.85   
Modified Care 5 0.61 0.31-1.19   
Therapy 13 0.57** 0.38-0.84   
Social Support 4 0.77 0.46-1.31   
Intervention Type    0.02(1) 0.88 
Biological 3 0.71 0.24-2.12   
Psychosocial 23 0.61** 0.50-0.84   
Intervention Type    0.82(1) 0.37 
EST 14 0.58** 0.39-0.87   
Non-EST 12 0.73* 0.54-1.00   
Control Group Type    1.13(2) 0.57 
Educational 4 0.82 0.53-1.25   
Placebo 3 0.71 0.24-2.12   
TAU 19 0.62** 0.46-0.83   
Intervention Timing    0.03(1) 0.87 
Pregnancy 16 0.70 0.47-1.05   
Postpartum 9 0.67** 0.50-0.90   
Type of Prevention    1.05(3) 0.79 
Indicated 2 0.62 0.36-1.07   
Selected 10 0.60* 0.38-0.97   
Selected/Indicated 9 0.60* 0.36-0.99   
Universal 5 0.84 0.48-1.46   
Criterion for Diagnosis    0.03(1) 0.87 
Clinical 12 0.64* 0.42-0.99   
Cutoff 14 0.67* 0.50-0.92   
Exclude Current MDE    0.27(1) 0.60 
No 17 0.68** 0.53-0.89   
Yes 9 0.56 0.29-1.10   
Psychotherapy Orientation    0.41(1) 0.52 
CBT 8 0.63* 0.41-0.97   
IPT 4 0.40 0.11-1.51   
Method of Psychotherapy 
Administration    0.71(1) 0.40 
Group 8 0.62 0.36-1.07   
Individual 5 0.46** 0.29-0.73   
† p < 0.10,* p < 0.05, ** p < 0.01, *** p < 0.001 
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Figure 1. Flow chart illustrating identification of included studies.  
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Figure 2. Funnel plot for studies assessing the difference between depressive symptoms 
between treatment and control conditions at 6 months postpartum. The asymmetric 
distribution of studies in the lower half of the funnel plot suggests that there are missing 
studies with negative effect sizes, in which control conditions would be superior to 
treatment conditions.  
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Figure 3. Funnel plot for studies assessing the difference in prevalence of depressive 
episodes between treatment and control conditions at 6 months postpartum. The 
asymmetric distribution of studies in the lower half of the funnel plot suggests that there 
are missing studies with odds ratios greater than 0, in which control conditions would be 
superior to treatment conditions.  
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General Discussion 
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 Overall, the results of the studies included in this dissertation contribute to our 
understanding of perinatal mood and anxiety disorders. These studies build on previous 
research on risk factors and interventions for these disorders. The results of these studies 
provide important guidance for clinicians and researchers with interests in perinatal 
mental health.  
 The studies included in Chapter 1 help further our understanding of an important 
risk factor for perinatal depression and anxiety: maternal attitudes. Beck’s cognitive 
model (1967, 1976, 1985) suggests that negative maternal attitudes could function as a 
specific vulnerability to perinatal depression and anxiety. Previous research into the role 
of maternal attitudes in the development of perinatal depression and anxiety had been 
limited by the need for a measure of maternal attitudes that was not confounded with 
women’s expectations or experiences of motherhood and by the limited validity and 
reliability of existing measures, particularly among first-time mothers (Sockol, 2008). We 
demonstrated that our measure, the Attitudes Toward Motherhood scale (AToM), is 
reliable and has good convergent validity with general cognitive biases and an existing 
measure of maternal attitudes. This measure provides researchers and clinicians with an 
important tool for the assessment of this construct.  
 Development of the Attitudes Toward Motherhood scale enabled us to then use 
this measure to assess the relationship between maternal attitudes and symptoms of 
depression and anxiety among first-time pregnant and postpartum mothers. We found that 
dysfunctional maternal attitudes were strongly predictive of symptoms of depression and 
anxiety. This was true even after controlling for general cognitive biases, which suggests 
that maternal attitudes contribute uniquely to risk for perinatal distress above and beyond 
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general cognitive style. Furthermore, both dysfunctional maternal attitudes and general 
cognitive biases predicted symptoms of depression and anxiety after controlling for 
marital satisfaction and social support, which are known robust risk factors for these 
symptoms. Interpersonal risk factors also continued to predict symptoms of depression 
and anxiety when cognitive risk factors were controlled for, which suggests that both 
cognitive and interpersonal risk factors play an important role in the development of 
symptoms of depression and anxiety.  
 While the results of the studies included in Chapter 1 have interesting 
implications for clinicians and researchers interested in developing interventions for 
perinatal depression and anxiety, these findings are too preliminary to directly lead to 
changes in our approach to interventions for these disorders. The overarching goals for 
the studies included in Chapters 2 and 3 was to synthesize research that has already been 
conducted on treating and preventing postpartum depression in order to assess the overall 
efficacy of interventions that have been subjected to scientific study and to examine 
whether there might be characteristics of studies or interventions that are systematically 
associated with differences in efficacy.  
 The results of the meta-analyses included in Chapter 2 provide strong evidence 
for the efficacy of psychotherapy and antidepressant medications in the treatment of 
perinatal depression. These analyses demonstrate that these interventions are associated 
with significant decreases in depressive symptoms over time and that interventions lead 
to significantly greater reductions in depressive symptoms as compared to control 
conditions. Perhaps the most interesting finding from this study is that interpersonal 
psychotherapy was more effective than cognitive-behavioral therapy. This is somewhat 
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surprising, as the results of the studies included in Chapter 1 suggest that both 
interpersonal and cognitive risk factors are strongly associated with symptoms of 
depression – thus we might expect that interventions targeting either interpersonal or 
cognitive factors might be equally efficacious. One possible explanation for this finding 
is that there were notable methodological differences between studies assessing 
interpersonal psychotherapy compared to cognitive-behavioral therapy. The ambiguity of 
this finding highlights the need for further research in this area, and particularly suggests 
that a head-to-head comparison of interpersonal psychotherapy and cognitive-behavioral 
therapy in a methodologically rigorous trial would be an important contribution to 
research in this area.  
 The results of the meta-analyses included in Chapter 3 provide evidence that 
preventive interventions for postpartum depression result in significant reductions in 
depressive symptoms and the prevalence of depressive episodes, although the magnitude 
of effect is smaller than found for treatment studies in Chapter 2. At six months 
postpartum, subjects in treated conditions had significantly lower levels of depressive 
symptoms than subjects in control conditions. Subjects were also 27% less likely to 
experience a depressive episode during the first six months postpartum when they 
received an intervention. Interestingly, we did not find differences among the different 
types of interventions, and there was no difference in the efficacy of cognitive-behavioral 
therapy and interpersonal psychotherapy. This provides additional evidence that this 
result in Chapter 2 may reflect methodological differences between the included studies, 
rather than a true difference between these types of psychotherapy.  
Limitations and Future Directions 
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 The studies included in this dissertation represent promising first steps toward a 
more full understanding of these disorders. Further research is necessary to build upon 
the results of these studies and to help answer the questions that they raise.  
 One of the major limitations of Chapter 1 was the cross-sectional design of the 
included studies. While the results of these studies are consistent with a diathesis-stress 
model of depression and anxiety, a longitudinal design is necessary to assess whether 
dysfunctional maternal attitudes are truly a risk factor for symptoms of depression and 
anxiety, or whether these attitudes may simply be a reflection of the symptoms 
themselves. We are currently conducting a follow-up study to assess whether 
dysfunctional maternal attitudes during pregnancy are predictive of symptoms of 
depression and anxiety at 12 weeks postpartum.  
 Another limitation of the studies included in Chapter 1 was that we limited our 
sample to women who were pregnant with, or had recently given birth to, their first child. 
We decided to limit our sample due to differences that we had observed in the 
relationships among cognitive biases, maternal attitudes, and depressive symptoms 
between primiparous and multiparous subjects in our previous research (Sockol, 2008). 
As a previously utilized measure of maternal attitudes had proven particularly 
problematic for first-time mothers, we wanted to ensure that our measure was reliable and 
valid among this population. Replication of the results of this study with a sample of 
multiparous subjects is necessary to demonstrate that this measure is reliable and valid 
among all childbearing women.  
 As for all meta-analyses, the studies included in Chapters 2 and 3 are limited by 
the availability and quality of research studies assessing the efficacy of treatments and 
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preventive interventions for perinatal depression. While the absolute number of studies 
included in these meta-analyses was comparable to that of similar meta-analyses, certain 
sub-groups of interventions were represented by small numbers of studies. Results 
regarding interventions represented by small numbers of studies should be interpreted 
with caution. For example, in Chapter 2, we identified only four studies of antidepressant 
medication. Three of these studies were open trials, and none of these studies assessed the 
efficacy of antidepressants among depressed pregnant women. This was also true in 
Chapter 3, in which we only identified two randomized controlled trials of antidepressant 
medication for the prevention of postpartum depression, both of which were initiated in 
the immediate postpartum period. Clinicians are sometimes reluctant to prescribe 
antidepressant medication for women who are pregnant or breastfeeding and there is 
evidence that the use of selective serotonin reuptake inhibitors during pregnancy is 
associated with increased risk for congenital malformations (Alwan, Reefhuis, 
Rasmussen, Olney, & Friedman, 2007; Bar-Oz et al., 2007; Wurst, Poole, Ephross, & 
Olshan, 2010). However, there is also evidence for an increased risk of relapse among 
women who discontinue antidepressant treatment during pregnancy (Cohen et al., 2006). 
In order for clinicians and patients to make fully informed decisions about the risks and 
benefits of treatment, further research assessing the efficacy of antidepressant 
medications among this population – particularly in comparison to psychotherapeutic 
treatments, which may have lower risks or be more acceptable to patients – is necessary.  
Perhaps more worrisome than the limited number of studies included in these 
meta-analyses, particularly for non-psychotherapeutic interventions, is evidence of 
publication bias in both treatment and prevention studies. In most of our analyses, 
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examination of funnel plots and Duval and Tweedie’s (2000) trim-and-fill procedure 
suggested that we were missing studies with non-significant findings. For our main 
analyses, we were able to utilize statistical corrections that can estimate the overall effect 
size if these missing studies were included. However, this is not possible for moderator 
analyses. It is possible that there are systematic differences among studies that are 
published versus unpublished that might bias the findings of our meta-analyses. For 
example, consider our finding in Chapter 3 that there is no significant difference in the 
prevalence of postpartum depressive episodes at 6 months postpartum between the 
different types of interventions. This finding is based on 13 studies of psychotherapeutic 
interventions, 5 studies of modified medical care, 4 studies of social support, and 2 
studies of antidepressant medication. If several unpublished studies represent randomized 
controlled trials of social support interventions that failed to find that they reduced the 
prevalence of postpartum depression during the postpartum period, we would expect to 
find a difference among intervention types if we were able to include these missing 
studies in our moderator analyses. Thus the evidence of publication bias found in these 
meta-analyses limits our confidence in our findings, particularly for moderator analyses.   
The inclusion criteria we followed in the two meta-analyses have their own 
limitations. In Chapter 2, we decided to limit the included interventions to 
psychotherapeutic interventions and antidepressant medications. Because effective 
treatments for depression in adult populations have been identified (Cuijpers, van Straten, 
Andersson, & van Oppen, 2008; Joffe, Sokolov & Streiner, 1996), our goal for this meta-
analysis was to assess the efficacy of established interventions among perinatal 
populations. As a result, we did not include other potential interventions, such as dietary 
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supplements or hormonal interventions. This allowed us to make more rigorous 
comparisons between treatments, but there is a risk that effective and acceptable 
treatments may have been excluded from our analyses. In Chapter 3, in contrast, we 
decided to include a much wider range of potential interventions. The strength of this 
approach is that we were able to identify a wide range of interventions that appear to be 
effective in reducing depressive symptoms and the prevalence of depressive episodes 
during the postpartum period. As women may be more receptive to complementary and 
alternative approaches to treatment, particularly during pregnancy, it is important for 
research to assess whether these approaches are efficacious (Battle, Uebelacker, Howard, 
& Castaneda, 2010). However, given the wide variations in intervention types, it was 
difficult to conduct direct comparisons of all of the interventions included in these 
analyses.   
Conclusions 
The cumulative results of these studies provide a hopeful message to clinicians, 
researchers, and mothers. In Chapter 1, we found that dysfunctional maternal attitudes, 
general cognitive biases, and interpersonal risk factors each have incremental predictive 
validity for symptoms of depression and anxiety. This provides evidence that emotional 
distress in this population is multi-factorial, and thus may be responsive to a wide range 
of approaches to intervention and prevention. The results of the meta-analyses in 
Chapters 2 and 3 provide further empirical support for this. Several types of 
antidepressant medications and psychotherapies were effective in the treatment of 
perinatal depression, and an even wider range of preventive interventions were found to 
effectively reduce depressive symptoms and the prevalence of depressive episodes during 
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the postpartum. The efficacy of such a wide range of interventions provides opportunities 
for selecting interventions that correspond with patients’ preferences and access to care. 
While women often express a preference for psychotherapeutic interventions during this 
time period, there are also practical barriers to access to care that may lead some women 
to prefer pharmacologic or other interventions (Kim et al., 2011).  
A more thorough understanding of the mechanisms that underlie the development 
of depression and anxiety during the perinatal period, and application of this 
understanding to the development of interventions to treat and prevent these disorders, is 
vitally important. These disorders are common and negatively affect not only the women 
who suffer from their symptoms, but also their developing children. While the context of 
pregnancy and the early postpartum period may confer additional risks, it also provides 
clinicians and researchers with opportunities – this is a time of increased access to and 
utilization of healthcare, and women may be particularly motivated to seek treatment by 
their desire to provide a healthy environment for their developing children. The studies 
included in this dissertation represent important steps toward an understanding of these 
disorders that can be used to help women achieve a healthy psychological adjustment 
during the transition to parenthood.  
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